Mark G. Davies, M.D., Ph.D., M.B.A.

Dr. Davies is Professor and Chief, Vascular and Endovascular Surgery at UT Health San Antonio and Director of Vascular and Endovascular Surgery at the University Hospital San Antonio. His clinical interests are focused on the management of complex aortic, carotid and lower extremity disease. He is a pioneer in new endovascular and molecular therapies and has participated in multiple clinical device and gene therapy trials. His clinical research is in vascular quality, vascular education and outcomes. His administrative interests relate to leadership development, managing human capital, enhancing service and quality operations, reporting and LEAN process improvement. Dr. Davies is also widely published in basic science on subjects related in arterial injury, vein graft remodeling and metabolic syndrome. His focus in these areas is Protease and G-protein biology. Dr. Davies is an active clinical teacher and mentor locally and nationally.

• Professional Background

  Education

  • 2017 - M.H.A. - Carlson School of Management
  • 2017 - M.S. (HQSM) - School of Population Health, Jefferson University
  • 2016 - C.H.F.P. - American College of Medical Practice Executives, Englewood, CO
  • 2015 - M.M.M. - Heinz College, College of Public Policy & Management, Carnegie Mellon University, Pittsburgh, PA
  • 2015 - C.M.P.E. - American College of Medical Practice Executives, Englewood, CO
  • 2014 - F.A.C.H.E. - American College of Health Care Executives, Chicago, IL
  • 2013 - Certified Patient Safety Officer - IHC-Institute of Health Care Delivery Research, Intermountain Health Care, Salt Lake City, UT
  • 2012 - C.P.E. - Certifying Commission on Medical Management, Tampa, FL
  • 2008 - M.B.A. - Simon Graduate School of Business Administration, University of Rochester, New York
  • 1999 - M.D. - Surgery - Trinity College Medical School, University of Dublin, Dublin, Ireland
  • 1999 - R.V.T. - Surgery - ARDMS (Vascular Technology), Rockville, MD
  • 1996 - PhD - Vascular Biology - Trinity College Medical School, University of Dublin, Dublin, Ireland
  • 1990 - F.R.C.S. (England) - Royal College of Surgeons of England, Dublin, Ireland
  • 1990 - F.R.C.S. (Ireland) - Royal College of Surgeons in Ireland, Dublin, Ireland
  • 1990 - M.R.C.P.I. (Part 1) - Royal College of Physicians of Ireland, Dublin, Ireland
  • 1989 - M.A., M.Sc. (Pharmacology) - Trinity College Medical School, University of Dublin, Dublin, Ireland
  • 1986 - B.A., M.B., B.Ch., B.A.O. - Medicine - Trinity College Medical School, University of Dublin, Dublin, Ireland

  Training

  • 2017 - Master of Health Administration - Executive MHA Program - University of Minnesota
  • 2017 - Master of Healthcard Quality & Safety Management - Executive MSc (Quality) Program - Jefferson University
  • 2016 - UHS LEAN Academy - Quality Course - University Hospital System
  • 2016 - THA Leadership Fellows Program - Leadership Course - Texas Hospital Association
  • 2016 - Certified Healthcare Financial Professional (CHFP) Program - Finance Course - Healthcare Financial Management Association
  • 2015 - Team STEPPS Master Trainer Certificate - Quality Course - AHRQ
  • 2015 - Master of Medical Management - Executive MMM Program - Carnegie Mellon University
  • 2014 - Certified Medical Practice Executive (CMPE) - Management Course - Medical Group Management Association
  • 2014 - ACHE Executive Development Program - Leadership Course - American College of Healthcare Executives (ACHE)
  • 2013 - Advance Training Program in Health Care Delivery Improvement Program - Quality Course - Intermountain Institute for Health Care Delivery Research
  • 2013 - Master Certificate in Applied Project Management - Project Management - Villanova University
  • 2012 - Basic and Advanced Patient Safety Certification - Quality Course - Harvard Quality Colloquium
  • 2012 - Master Black Belt Six Sigma - Quality Course - Villanova University
  • 2012 - Black Belt Six Sigma - Quality Course - Villanova University
  • 2012 - Green Belt Six Sigma - Quality Course - University of Houston
  • 2012 - Certifying Commission on Medical Management - CPE Program - American College of Physician Executives
  • 2008 - Executive MBA - Executive MBA Program - William E. Simon Graduate School of Business Administration
  • 2007 - "Leadership Program in Health Policy and Management" - Leadership Program - Brandeis University
  • 2007 - TeamSTEPPStm-Patient Safety Course - Quality Course - University of Rochester
  • 2006 - Patient Safety Course - Quality Course - University of Rochester
  • 2006 - "Surgeons as Leaders: From Operating Room to Boardroom" - Leadership Course - American College of Surgeons
  • 2006 - "Leadership Development for Physicians in Academic Health Centers" - Leadership Course - Harvard School of Public Health
  • 1999 - Fellow - Vascular Surgery - University of Washington, Seattle, WA
  • 1997 - Chief Resident - General Surgery - Duke University Medical Center, Durham, North Carolina
  • 1996 - Resident - General Surgery - Duke University Medical Center, Durham, North Carolina
  • 1994 - Research Fellow - Vascular - Duke University Medical Center, Durham, North Carolina
  • 1991 - Resident - General Surgery - Royal College of Surgeons in Ireland, Surgical Training Scheme (Dublin Region)
  • 1988 - Research Associate - Medical - Trinity College Medical School, University of Dublin, Dublin, Ireland
  • 1987 - Surgical Intern - Medical - St. James's Hospital, University of Dublin, Dublin, Ireland
  • Master of Medical Informatics (Ongoing) - Executive MMI Program - Northwestern University
  • Master of Health Professional Education (Ongoing) - Executive MHPE Program - University of Illinois, Chicago

• Research & Grants

  Grants

  PATENTS
  Bioengineered vascular graft support prostheses
  Patent number: 7041131
  Filing date: Apr 11, 2003
  Issue date: May 9, 2006
  Inventors: Ginger A. Abraham, Robert M. Carr, Jr., Tam Huynh, Per Otto Hagen, Mark Davies
  Assignees: Organogenesis, Inc.
  Primary Examiner: Corrine McDermott
  Secondary Examiner: Hieu Phan
  Attorney: Kramer Levin Naftalis & Frankel LLP
  Application number: 7041131, U.S. Classification 623/147;623/142

  2012 NSF – Sub-Investigator
  (1yrs; PI M Garbey) $ 50,000.00
  ”IUCRC for Cyber-Physical Systems for the Hospital Operating Room”

  2011 VEF - Vietnam Education Fund – Sub-Investigator
  (3yrs; PI M Garbey) $ 100,000.00
  ”Computational Surgery”

  2011 EU-USA Atlantis Program – USATD 180626 Sub-Investigator
  (3yrs; PI M Garbey) € 428,000.00
  ” International Dual Degree in Computing Robotics and Imaging for Surgery
  Platform (CRISP) Computer, Robotics for Surgery”

  2009 NSF – CPS (0932272) Consultant
  (3 yrs; PI, N Tsekos) $ 1,400,000
  “Image Guided Robot-Assisted Medical Interventions”

  2007 NIH- NHLBI (HL086968) Principal Investigator
  RO1 (7 yrs; PI, M.G. Davies) $ 1,900,000
  “Phospholipids, metabolic syndrome and response to injury.”

  2011 NIH – NIDNS R01NS070308 Site Principal Investigator
  (5 yrs; PI, W Zhou) $ 469,666.00
  “Long-term Effects of Subclinical Microembolization associated
  with Carotid Interventions”

  2008 NIH- NHLBI (U01-HL088476 and U01-HL088118) Site Sub Investigator
  U01 (5 yrs; PI, S. Vedantham and C. Kearon)
  “Acute Venous Thrombosis: Thrombus Removal with
  Adjunctive Catheter-Directed Thrombolysis (ATTRACT)”

  2008 NIH- NHLBI (U01 HL077221) Site Principal Investigator
  U01 (5 yrs; PI, T. P. Murphy)
  “Claudication: Exercise vs. Endoluminal Revascularization (CLEVER)

  2005 NIH (T32 HL07937) Faculty
  T32 - Institutional National Research Service Award (5 yr. PI, T.A Pearson)
  “Research Training in Preventive Cardiology”

  2004 NIH (T32 GM 07356) Faculty
  T32 - Institutional National Research Service Award (7/04-6/09, 5 yr; PI, K O’Banion)
  “Medical Scientist Training Program Grant”

  2003 NIH (NS 038384) Site Sub Investigator
  RO-1 (01/05-02/09; 5 yrs; PI, R Hobson)
  “Carotid Revascularization: Endarterectomy versus Stent Trial (CREST).”

  2004 NIH (R44 HL 066688) Consultant
  SBIR – Phase II – Organ Recovery Systems (P.I. Y Song)
  “Vitrification for tissue engineered blood vessels”.

  2004 NIH (HL 015448) Site Sub Investigator
  RO-1 (10/04-9/09; 5 yrs; PI, T Murphy)
  “Cardiovascular Outcomes with Renal Atherosclerotic Lesions (CORAL)”

  2001 NIH-NHLBI / Lifeline Foundation (K08 HL 67746) Principal Investigator
  Mentored Clinical Scientist Development Award (10/01-09/06, 5 yr; PI, M.G. Davies) US$ 800,000
  “uPA receptor signaling and cell migration”

  2000 American College of Surgeons Principal Investigator
  Junior Faculty Award (7/00-6/02; 2 yrs; PI, M.G. Davies) US$ 70,000
  “Extracellular matrix biology of vein graft intimal hyperplasia”

  2000 Eastern Vascular Society Principal Investigator
  Young Investigator’s Award (1 yr; PI, M.G. Davies) US$ 5,000
  “Role of Gαq subunit in the development of intimal hyperplasia”

  2000 NIH (T32 HL 0794) Faculty
  T32 - Institutional National Research Service Award (7/00-6/05; 5 yrs; PI, B Berk) US$ 1,924,253
  “ Cardiovascular Research Training Program”

  1994 NIH-NHLBI Sub-Investigator
  RO-1 (HL015448; 7/94-6/99; 5 yrs; PI, P-O Hagen) US$ 1,200,000
  “Surgical and metabolic aspects of vein graft failure”

  1992 American Heart Association (NC affiliate) Principal Investigator
  Grant-in-Aid (NC 92-GB-31; 1 yr; PI, M.G. Davies). US$ 9,743
  “The effects of systemic vascular diseases on vein graft morphology and function”.

   

   

• Service

  School

  University of Texas / University Hospital:

  Director, Vascular/Endovascular Surgery and Imaging Services 2015 to date
  Co-leader, Heart and Vascular Insitute 2015 to date

  Member, OR Steering Committee 2015 to date
  Member, Hospital Performance Council 2015 to date
  Member, Organizational Performance Council 2015 to date

  ****More upon request

   

      

  Institutional

  Weill-Cornell / The Methodist Hospital:   

  Program Director, Integrated Vascular Surgery Residency 2010 to 2014
  Program Director, Vascular Surgery Fellowship 2008 to 2014
  Director, TMH Vascular Diagnostic Lab 2009 to 2014
  Interim Departmental Administrator 2011 to 2012
  Interim Revenue Cycle Manager 2008

  *****More upon request 

  Community Service

  Society of Vascular Surgery
  Clinical Practice Council 2017 to 2020
  APM SubCommittee 2017 to 2019
  Education Council 2013 to 2015
  Governing Council of SVS-PSO 2011 to 2014
  Quality SubCommittee 2011 to 2013
  Research SubCommittee 2011 to 2012
  Reporting Standards Committee – FEVAR 2013 to 2017
  Document Oversight Committee 2012 to 2013, 2018 to 2019
  ***More upon request

• Publications

  Manuscripts:

  Davies MG. An analysis of the effects of methyl glyoxal on central synaptic transmission. Medical Research Council of Ireland (MRCI) Annual Report 1983:141-142.

  Chambers PL, Davies MG, Rowan MJ. The effects of methylglyoxal on the central synaptic transmission in the isolated nerve cord of the cockroach. Arch Toxicol 1985; Suppl 8:337-341.

  Davies MG, Chambers PL, Rowan MJ. Methyl glyoxal and cholinergic transmission in the central and peripheral nervous system. Arch Toxicol 1986; Suppl 9:46-50.

  O’ Connor P, Davies MG, Feely J. Emphysematous cystitis: another alcohol-related problem? Ir Med J 1987; 80:420-421. Davies MG, Daly PA, Walsh A. Deaths in a haematology/oncology unit - the St James’s experience-an analysis of 251 cases. Ir Med J 1987; 80:117-119.

  Davies MG, Gaine SP, Tadros E, McEntee GP, Gorey TF, Hennessy TPJ. Combined external and internal biliary fistulae treated by percutaneous cholecystolithotomy. Br J Surg 1989; 76:1258.

  Davies MG, Halpin DP, O’Byrne P, Stephens RB. Primary pneumococcal peritonitis - a brief report. Ir J Med Sci 1989; 158:307.

  Davies MG, O’Dowd G, McEntee GP, Hennessy TPJ. Primary gastric carcinoids - a view on their management. Br J Surg 1990; 77:1013-1014.

  Davies MG, O’Byrne P, Stephens RB. Perforated appendicitis presenting as an irreducible inguinal hernia. Br J Clin Pract 1990; 44:494-495.

  Davies MG, Feeley TM, Moore DJ, Shanik DG. Home parenteral nutrition using a totally implanted subcutaneous venous access device. Br J Clin Pract 1990; 44:750.

  Davies MG, Rowan MJ, Feely J. Flash visual evoked responses in early hepatic encephalopathy of chronic liver disease. Scand J Gastroenterol 1990; 25:1205-1214.

  Davies MG, Rowan MJ, MacMathuna P, Keeling PWN, Weir DG, Feely J. The auditory P300 event related potential: an objective marker of the encephalopathy of chronic liver disease. Hepatology 1990; 12:688-694.

  Bough B, Thakore J, Davies MG, Dowling F. Degeneration of the lumber facet joints - arthrography and pathology. J Bone Joint Surg [Br] 1990; 72-B:275-276.

  Davies MG, O’Malley MK, Feeley TM, Moore DJ, Shanik DG. Brachial embolus - a timely diagnosis. Ann Vasc Surg 1991; 5:85-87.

  Davies MG, O’Broin E, O’Sullivan BJ, Lennon F. A bladder full of stones - a case report. Ir Med J 1991; 84:28.

  Davies MG, Rowan MJ, Feely J. Psychometrics in assessing hepatic encephalopathy - a brief review. Ir J Psychol Med 1991; 8:144-146.

  Rowan MJ, Davies MG. Effects of methyl glyoxal on adrenergic transmission in the isolated rabbit intestine. Toxicology In-Vitro 1991; 5:169-172.

  Davies MG, Feeley TM, O’Malley MK, Colgan MP, Moore DJ, Shanik GD. Infrainguinal polytetrafluoroethylene grafts: saved limbs or wasted effort? A report on ten years’ experience. Ann Vasc Surg 1991; 5:519-524.

  Davies MG, Rowan MJ, Feely J. EEG and event related potentials in hepatic encephalopathy. Metab Brain Dis 1991; 6:175-186.

  Davies MG, Shine MF, Lennon F. Surgical audit under scrutiny - a prospective study. Ir J Med Sci 1991; 160: 299-302.

  Davies MG, Shine MF, Lennon F. Surgical emergencies in Ireland - an audit of the emergency caseload of a district general surgical unit. Ir J Med Sci 1991; 160:303-306.

  Davies MG, O’Broin E, McGinley J, Mannion C, Gupta S, Shine MF, Lennon F. An audit of open cholecystectomy in district general hospital. Br J Surg 1992; 79:314-316.

  Suhr C, Davies MG, Schwartz LB, O’Donohoe MK, Mikat EM, Hagen P-O. Human cadaveric coronary artery vasoreactivity is dependent on anatomic location and post-mortem interval. Coronary Artery Disease 1992; 3:847-851.

  Hagen P-O, Davies MG, Schuman RW, Murray JJ. Reduction of vein graft intimal area by ex-vivo treatment with desferroxamine manganese. J Vasc Res 1992; 29:405-409.

  Lavelle J, Davies MG, Connolly JA, O’Broin E, Shine MF, Lennon F. A review of the nature and activity of a general surgical service in Ireland. Ir J Med Sci 1992; 161:127-130.

  Davies MG, Brockbank KGM, Hagen P-O. The relationship of human saphenous vein intimal area to age and gender. Vascular Surgery 1992; 26:700-704.

  Davies MG, Connolly JA, Murphy C, O’Kane G, Mc Dowell C, Shine MF, Lennon F. Intensive care in an Irish district general hospital - a 3 year review. Ir Med J 1993; 86:10-12.

  Davies MG, Klyachkin ML, Dalen H, Massey MF, Svendsen E, Hagen P-O. The integrity of experimental vein graft endothelium-implications on the etiology of early graft failure. Eur J Vasc Surg 1993; 7:156-165.

  Davies MG, Klyachkin ML, Dalen H, Svendsen E, Hagen P-O. Regression of intimal hyperplasia with restoration of EDRF-mediated relaxation in experimental vein grafts. Surgery 1993; 114:258-271.

  Davies MG, Klyachkin ML, Kim JH, Hagen P-O. Endothelin and vein bypass grafts in experimental atherosclerosis. J Cardiovasc Pharmacol 1993; 22(Suppl 8):S348-S351.

  Davies MG, Hagen P-O. The vascular endothelium - a new horizon. Ann Surg 1993; 218: 593-609.

  Davies MG, Kim JH, Klyachkin ML, Kim YC, Svendsen E, Carson CC, Hagen P-O. Diabetes mellitus increases intimal hyperplasia and smooth muscle cell dysfunction in experimental vein graft. Surgical Forum 1993; XLIII:388-390.

  Davies MG, Hagen P-O. Functional consequences of vein bypass grafting. In: Vascular Surgery (Volume One of Two). Eds. Wang Z-G, Becker, H-M, Mishima Y, Chang JB. International Academic Publishers, Beijing, China, 1993; 450-454.

  Davies MG, Klyachkin ML, Massey MF, Svendsen E, Hagen P-O. Responses of experimental vein grafts to endothelin-1. J Vasc Med Biol 1993; 4: 243-249.

  Massey MF, Davies MG, Klyachkin ML, Schwartz LB, Barber L, McCann RL, Hagen P-O. Bradykinin responses in experimental vein grafts. J Vasc Med Biol 1993; 4:122-129.

  Brockbank KGM, Harris SJ, Nardiello C, Davies MG, Pallos LL, Hagen P-O. Evaluation of a simplified saphenous vein procurement technique. J Transplant Co-ordination 1993; 3:39-43.

  Klyachkin ML, Davies MG, Svendsen E, Kim JH, Massey MF, Barber L, Hagen P-O. Hypercholesterolemia and experimental vein grafts. Accelerated development of intimal hyperplasia and abnormal vasomotor function. J Surg Res 1993; 54:451-468.

  Massey MF, Davies MG, Svendsen E, Klyachkin ML, Schwartz LB, Barber L, McCann RL, Hagen P-O. Ketanserin inhibits experimental vein graft intimal hyperplasia. J Surg Res 1993; 54: 530-538.

  39. Kim JH, Davies MG, Kim YC, Hagen P-O, Carson CC. Alloxan-induced diabetes does not impair cavernosal relaxation in vitro or penile erection in vivo. Surgical Forum 1993; XLIV:752-754.

  Davies MG, Hagen P-O. Structural and functional consequences of bypass grafting with autologous vein. Cryobiology 1994; 31: 63-70.

  Davies MG, Kim JH, Klyachkin ML, Dalen H, Svendsen E, Carson CC, Hagen P-O. Diabetes mellitus and experimental vein graft morphology and function. J Vasc Surg 1994; 19:1031-1043.

  Davies MG, Hagen P-O. Influence of peri-operative storage solutions on long-term vein graft function and morphology. Ann Vasc Surg 1994; 8:150-157.

  Davies MG, Barber L, Dalen H, Svendsen E, Hagen P-O. Pharmacologic control of the structural and functional consequences of vein graft intimal hyperplasia by a 21-aminosteroid (U74389G). Eur J Vasc Surg 1994; 8:448-456.

  Davies MG, Hagen P-O. Modeling the pathophysiology of vein graft failure J Vasc Surg 1994; 20:139-140.

  Davies MG, Hagen P-O. Bradykinin receptor modulation in vein grafts. J Invest Surg 1994; 7: 493-501.

  Davies MG, Kim JH, Makhoul RG, Dalen H, Svendsen E, Hagen P-O. Reduction of intimal hyperplasia and preservation of NO-mediated relaxation by the NO precursor: L-arginine. Surgery 1994; 116: 557-568.

  Davies MG, Klyachkin ML, Barber L, Svendsen E, Hagen P-O. Ramipril and experimental vein graft intimal hyperplasia. Angiology 1995; 46:91-97.

  Davies MG, Kim JH, Barber L, Dalen H, Svendsen E, Hagen P-O. Systemic hypertension and hypercholesterolemia in vein grafts: effects on the function and morphology of experimental vein grafts. J Surg Res 1994; 57: 106-121.

  Davies MG, Dalen H, Svendsen E, Hagen P-O. The functional and morphological consequences of balloon catheter injury in veins. J Surg Res 1994; 57:122-131.

  Davies MG, Hagen P-O. Pathobiology of intimal hyperplasia. Br J Surg 1994; 81: 1254-1269.

  Davies MG, Ramkumar V, Gettys T, Hagen P-O. The expression and function of G-proteins in experimental intimal hyperplasia. J Clin Invest 1994; 94: 1680-1689.

  Kim JH, Klyachkin ML, Svendsen E, Davies MG, Hagen P-O, Carson CC. Experimental hypercholesterolemia in rabbits induces cavernosal atherosclerosis with endothelial and smooth muscle cell dysfunction. J Urol 1994; 151: 198-205.

  Cross KS, Davies MG, El-Sanadiki MN, Murray JJ, Mikat EM, Hagen P-O. Long-term human vein graft contractility and morphology: A functional and histopathological study of retrieved coronary vein grafts. Br J Surg 1994; 81: 699-705.

  O’Donohoe MK, Davies MG, Radic ZS, Mikat EM, Hagen P-O. Increased local activity of angiotensin converting enzyme in experimental vein grafts. J Cardiovasc Pharmacol 1994; 23: 594-601.

  Kim YC, Davies MG, Hagen P-O, Carson CC. Experimental evidence for endothelium dependent relaxation and neuronal nitric oxide in corpus cavernosum. Yonsei Med J 1994; 35:308-313.

  Klyachkin ML, Davies MG, Kim JH, Barber L, Dalen H, Svendsen E, Hagen P-O. Post-operative reduction of high serum cholesterol concentrations and experimental vein bypass grafts: Effect on the development of intimal hyperplasia and abnormal vasomotor function. J Thorac Cardiovasc Surg 1994;  07:556-566.

  Kim YC, Davies MG, Marson L, Hagen P-O, Carson CC. The lack of effect of carbon monoxide on electrical field stimulation induced relaxation in corpus cavernosum. Urol Res 1994; 22:291-293.

  Brockbank KGM, Davies MG, Fields SM, Hagen P-O. The relationship of human saphenous vein smooth muscle cell contractile responses to donor age and gender. Vascular Surgery 1995; 29:15-21.

  Kim YC, Davies MG, Lee T-H, Hagen P-O, Carson CC. Characterization and function of histamine receptors in the rabbit corpus cavernosum. J Urol 1995; 153:506-510.

  Kim YC, Kim JH, Davies MG, Hagen P-O, Carson CC. Modulation of vasoactive intestinal polypeptide (VIP)-mediated relaxation by nitric oxide and prostanoids in the rabbit corpus cavernosum. J Urol 1995; 153:807-810.

  Fulton GJ, Davies MG, Hagen P-O. Locally applied antisense oligonucleotide to proto-oncogene c-myb inhibits the formation of intimal hyperplasia in experimental vein grafts. Surgical Forum 1995; XLVI:342-345.

  Davies MG, Hagen P-O. Pathophysiology of vein graft failure. Eur J Vasc Endovasc Surg 1995; 9: 7-18.

  Davies MG, Klyachkin ML, Kim JH, Svendsen E, Hagen P-O. Prolonged hypercholesterolemia induces reversible alterations in venous vasomotor function. J Invest Surg 1995; 8:43-50.

  Davies MG, Dalen H, Kim JH, Barber L, Svendsen E, Hagen P-O. The influence of the combined presence of diabetes mellitus and hypercholesterolemia on the function and morphology of experimental vein grafts. Eur J Vasc Endovasc Surg 1995; 9: 142-155.

  Davies MG, Kim JH, Svendsen E, Dalen H, Hagen P-O. Control of the accelerated vein graft atheroma with the Nitric Oxide precursor: L-arginine. J Surg Res 1995; 59:35-42.

  Davies MG, Berkowitz DE, Hagen P-O. Expression and function of endothelial cell constitutive nitric oxide synthase in retrieved human aorto-coronary vein grafts. J Surg Res 1995; 58: 732-738.

  Davies MG, Fulton GJ, Hagen P-O. Clinical Biology of Nitric Oxide. Br J Surg 1995; 82:1598-1610.

  Davies MG, Klyachkin ML, Dalen H, Svendsen E, Hagen P-O. The initial morphological fate of the in-situ vein bypass. CellVision-Journal of Analytical Morphology 1995; 2:289-295.

  Davies MG, Klyachkin ML, Massey MF, Svendsen E, Hagen P-O. A comparative study of EDRF-mediated relaxation and smooth muscle cell function in arterial and venous vein bypass grafts. Cardiovasc Surg 1996; 4:150-160.

  Davies MG, Dalen H, Barber, E, Austarheim A-M, Gulbrandsen TF, Svendsen E, Hagen P-O. Suppression of intimal hyperplasia in experimental vein grafts by oral L-arginine supplementation and single ex-vivo immersion in desferrioxamine manganese. J Vasc Surg 1996; 23: 410-420.

  Davies MG, Hagen P-O. Kinetics of altered angiotensin II responses in experimental vein grafts J Invest Surg 1996; 423-432.

  Davies MG, Fulton GJ, Barber E, Dalen H, Svendsen E, Hagen P-O. Suppression of angiotensin II responses and inhibition of intimal hyperplasia in experimental vein grafts by the specific angiotensin II receptor inhibitor, L158,809. Eur J Vasc Endovasc Surg 1996; 12: 151-161.

  Davies MG, Hopkins MA, Brockbank KGM, Hagen P-O. Hypothermia and rewarming after hypothermic exposure alter endothelial dependent venous relaxation. Vascular Medicine 1996; 1:103-107.

  Davies MG, Ramkumar V, Hagen P-O. Temporal expression of G-proteins in intimal hyperplasia. J Surg Res 1996; 63:115-122.

  Davies MG, Barber E, Dalen H, Svendsen E, Hagen P-O. Lazaroid therapy (methylaminochroman:U83836E) reduces experimental vein graft intimal hyperplasia. J Surg Res 1996; 63:128-136.

  Davies MG, Dalen H, Svendsen E, Hagen P-O. Balloon catheter injury and vein graft morphology and function. Ann Vasc Surg 1996; 10: 429-442.

  Davies MG, Hagen P-O. Alterations in venous endothelial cell and smooth muscle cell relaxation induced by high glucose concentrations can be prevented by aminoguanidine. J Surg Res 1996; 63:474-479.

  Davies MG, Hagen P-O. The influence of L-arginine therapy on venous endothelial and smooth muscle cell dysfunction induced by hypercholesterolemia. J Invest Surg 1996; 9: 415-422.

  Barry MC, Gul Y, Davies MG, Long D, Shine MF, Lennon F. Changing trends in acute peptic ulcer surgery in a district surgical unit. Ir J Med Sci 1996; 165:109-112.

  Anstadt MA, Perez-Tamayo RA, Davies MG, Hagen P-O, Anstadt GL, Lowe JE. Experimental aorto-coronary saphenous vein graft function after mechanical cardiac massage with the Anstadt Cup. ASAIO Journal 1996; 42:295-300.

  Fulton GJ, Davies MG, Svendsen E, Lefkowitz RJ, Koch W, Hagen P-O. Transfection with βARKCT reduces intimal hyperplasia formation in experimental vein grafts. Surgical Forum 1996; XLVII:341-345.

  Davies MG, Dalen H, Svendsen E, Hagen P-O. Influence of peri-operative catheter injury on the long-term vein graft function and morphology. J Surg Res 1996; 66:109-114.

  Fulton GJ, Davies MG, Barber L, Dalen H, Svendsen E, Hagen P-O. Locally applied antisense oligonucleotide to the proto-oncogene c-myb inhibits the formation of intimal hyperplasia in experimental vein grafts. J Vasc Surg 1997; 25:453-463.

  Huynh TTT, Davies MG, Annex BH, Svendsen E, Hagen P-O. Reduction of intimal hyperplasia by local modulation of NF-κB activity in experimental vein grafts. Surgical Forum 1997; XLVIII: 441-444.

  Fulton GJ, Davies MG, Hagen P-O. Preservation of the endothelium in arterial vein bypass grafts: relevance for graft patency Asia Pacific Heart J 1997; 6:98-106.

  Channon KM, Fulton GJ, Davies MG, Peters KG, Ezekowitz MD, Hagen P-O, Annex BH. Intimal Tissue Factor Protein expression precedes intimal hyperplasia in experimental venous bypass grafts. Arterioscler Thromb Vasc Biol 1997; 17:1313-1319.

  Fulton GJ, Svendsen E, Hagen P-O, Davies MG. Oral D-limonene therapy (perillyl alcohol) reduces vein graft intimal hyperplasia. J Surg Res 1997; 69:128-134.

  Davies MG, Hopkins MA, Brockbank KGM, Hagen P-O. The influence of hypothermia (20°C) and rewarming (37°C) on venous smooth muscle cell function. Vascular Surgery 1997; 31:441-449.

  Davies MG, Annex BH, Channon KM, Denning SM, Taylor DA, Fulton GJ, Peters KG, George SE, Hagen P-O. Alteration of arterial vasomotor function by gene transfer with a replication deficient adenovirus. Vascular Surgery 1997; 31:131-136.

  Davies MG, Klyachkin ML, Dalen H, Svendsen E, Hagen P-O. The early morphology of veno-venous bypass grafts. Cardiovasc Surg 1997; 5: 82-91.

  Davies MG, Hagen P-O. Vein graft adaptation in the arterial circulation. J Vasc Surg 1997; 25:1099-1100 and J Vasc Intervent Radiol 1997; 8:697-699.

  Davies MG, Dalen H, Svendsen E, Hagen P-O. A study of the functional and histological differences in autologous and allogenic vein grafts - two different vasculopathies? J Surg Res 1997; 69:14-22.

  Davies MG, Hagen P-O. Systemic Inflammatory Response Syndrome. Br J Surg 1997; 84: 920-935.

  Davies MG, Huynh TTT, Fulton GJ, Lefkowitz RJ, Svendsen E, Hagen P-O, Koch WJ. G-protein signaling and vein graft intimal hyperplasia: Reduction of intimal hyperplasia in vein grafts by a Gβγ inhibitor suggests a major role of Gprotein signaling in lesion development. Arterioscler Thromb Vasc Biol 1998;18:1275-1280.

  Davies MG, Ramkumar V, Hagen P-O. Adenosine receptor function in experimental vein bypass grafts. J Vasc Surg 1998; 28:929-39.

  Fulton GJ, Davies MG, Barber E, Svendsen E, Hagen P-O. Localized versus systemic angiotensin II receptor inhibition of intimal hyperplasia in experimental vein grafts by the specific angiotensin II receptor inhibitor, L158,809. Surgery 1998; 123:218-227.

  Fulton GJ, Davies MG, Gray JL, Barber L, Svendsen E, Hagen P-O. Local effects of nitric oxide supplementation and suppression in the development of intimal hyperplasia in experimental vein grafts. Eur J Vasc Endovasc Surg 1998; 15:279-289.

  Huynh TTT, Davies MG, Svendsen E, Hagen P-O. Reduction of intimal hyperplasia by inhibition of tyrosine kinase activity in experimental vein graft. J Surg Res 1998; 77:104-111.

  Huynh TTT, Iaccarino G, Peppel KC, Davies MG, Koch WJ, Hagen P-O. Adenoviral mediated inhibition of Gβγ subunit limits the formation of intimal hyperplasia in vein grafts. Surgery 1998; 124:177-186.

  Fulton GJ, Davies MG, Barber E, Svendsen E, Hagen P-O. Locally applied antisense oligonucleotide to proliferating cell nuclear antigen (PCNA) inhibits intimal hyperplasia formation in experimental vein grafts. Ann Vasc Surg 1998; 12: 412-417.

  Fulton GJ, Channon KM, Denning SM, Davies MG, Hagen P-O, Annex BH. Alteration in vein graft extracellular matrix composition: analysis of collagen expression. Coronary Artery Disease 1998; 9:191-197.

  Daum G, Kalmes A, Levkau B, Wang Y, Davies MG, Clowes AW. p38MAPK inhibits activation of mitogen activated protein kinase kinase-1 in oxidative stress signaling. FEBS Lett 1998; 427:271-274.

  Huynh TTT, Davies MG, Annex BH, Peters KG, Thompson MA, Hagen P-O. Biological significance of VEGF modulation following experimental bypass grafting. Surgical Forum 1998; XLIX:320-322.

  Annex BH, Davies MG, Fulton GJ, Huynh TTT, Channon KM, Ezekowitz MD, Hagen P-O. Local delivery of an anti-rabbit Tissue Factor antibody reduces early leukocyte infiltration but fails to limit intimal hyperplasia in experimental vein grafts. J Surg Res 1998; 80: 164-170.

  Davies MG, Hagen P-O. Diabetes attenuates the alterations in both venous endothelial and smooth muscle cell function induced by prolonged hypercholesterolemia in an experimental model. J Invest Surg 1999; 12:107-114.

  Davies MG, Fulton GJ, Svendsen E, Hagen P-O. Time course of the regression of intimal hyperplasia in experimental vein grafts. Cardiovasc Pathol 1999; 8:161-168.

  Davies MG, Huynh TTT, Fulton GJ, Svendsen E, Brockbank KGM, Hagen P-O. Controlling transplant vasculopathy in cryopreserved vein grafts with PEG and glutathione during transport. Eur J Vasc Endovasc Surg 1999; 17:493-400.

  Davies MG, Huynh TTT, Fulton GJ, Barber E, Svendsen E, Hagen P-O. Early morphology of accelerated vein graft atheroma in experimental vein grafts. Ann Vasc Surg 1999; 13:378-85.

  Davies MG, Huynh TTT, Hagen P-O. Functional characterization of alpha-1 adrenergic receptors in experimental vein grafts J Surg Res 1999; 84:40-45.

  Davies MG, Huynh TTT, Fulton GJ, Barber E, Svendsen E, Hagen P-O. Combination therapy of cholesterol reduction and L-arginine supplementation prevents accelerated vein graft atheroma. Ann Vasc Surg 1999; 13:484-493.

  Huynh TTT, Davies MG, Trovato MJ, Svendsen E, Hagen P-O. Adjustment of hemodynamic perturbations by an external bioprosthetic collagen tube support modulates tyrosine kinase signaling and minimizes the development of intimal hyperplasia in vein grafts. J Vasc Surg 1999; 29:334-344.

  Clowes AW, Berceli S, Davies MG. Regulation of intimal growth and regression by blood flow. J Vasc Surg 1999; 29:1140-1151 and J Vasc Intervent Radiol 1999;10 945-946.

  Huynh TTT, Davies MG, Trovato MJ, Safi H, Hagen P-O. Reduction of lipid peroxidation with intra-operative SOD supplementation minimizes the development of intimal hyperplasia in vein grafts. J Surg Res 1999; 84:223-232.

  Huynh TTT, Iaccarino G, Davies MG, Koch WJ, Hagen P-O. Modulation of G-protein expression and coupling in vein grafts by external stenting. Surgery 1999; 126:127-134.

  Davies MG, Owens EL, Lea H, Mason DP, Tran PK, Vergal S, Hawkins SA, Hart CE, Clowes AW. Effect of PDGF receptor-α and -β blockade on flow induced neo-intimal formation in endothelialized baboon vascular grafts. Circ Res 2000; 86:779-786.

  Davies MG, Huynh TTT, Hagen P-O. Characterization of dopamine responses in experimental vein grafts. J Surg Res 2000; 92:103-107.

  Davies MG, Mason DP, Tran PK, Hawkins SA, Clowes AW. G-protein expression and intimal hyperplasia after arterial injury: a role for Gαi proteins. J Vasc Surg 2001; 33:408-418.

  Davies MG, Roztocil E, McKillop I, Green RM. Role of Gαq in smooth muscle cell proliferation following injury. Surgical Forum 2001; LII:374-377.

  Davies MG. G-proteins and Intimal Hyperplasia. J Vasc Surg 2001; 33: 1310-1312.

  Huynh TTT, Davies MG, Ezekowitz MD, Peters KG, Hagen P-O, Annex BH. Local treatment with Tissue Factor Pathway Inhibitor reduces the development of intimal hyperplasia in experimental vein grafts. J Vasc Surg 2001; 33:400-407.

  Yutan E, Glickerman D, Hatsukami T, Caps MT, Harley JD, Kohler,TR, Davies MG. Percutaneous transluminal revascularization for renal artery stenosis : the Seattle VAMC experience. J Vasc Surg 2001; 34:685-93.

  Illig KA, Rhodes JM, Sternbach Y, Shortell CK, Davies MG, Green RM. Reduction in wound mortality rates following endoscopic saphenous vein harvest. Ann Vasc Surg 2001; 15:104-109.

  Illig KA, Williams JP, Lyden SP, Hernady E, Soni A, Davies MG, Schell M, Okunieff P, Rubin P, Green RM. External beam irradiation for inhibition of intimal hyperplasia following prosthetic bypass: preliminary results. Ann Vasc Surg 2001; 15:533-8.

   Kenagy RD, Fischer JW, Davies MG, Berceli SA, Sandy J, Hawkins SM, Wight TN, Clowes AW. Increased Plasmin and Serine Proteinase Activity during Flow-Induced Intimal Atrophy in Baboon PTFE Grafts. Arterioscler Thromb Vasc Biol 2002; 22:400-4.

  Berceli SA, Davies MG, Kenagy RD, Clowes AW. Flow-Induced Intimal Regression in Baboon PTFE Grafts is Associated with Decreased Cell Proliferation and Increased Apoptosis. J Vasc Surg 2002; 36:1248-55.

  Sternbach Y, Zhang R, Illig KA, Shortell CK, Rhodes JM, Davies MG, Lyden SP Green RM. Hemodynamic Benefits of Regional Anesthesia for Carotid Endarterectomy. J Vasc Surg 2002; 35:333-9.

  Halaby IA, Lyden SP, Davies MG, Roztocil E, Salamone LJ, Brooks AI, Green RM, Federoff HJ, Bowers WJ. Glucocorticoid-regulated angiogenesis in ischemic skeletal muscle. Molecular Therapy 2002; 5:300-306.

  Illig KA, Sternbach Y, Zhang R, Burchfil J. Shortell CK, Rhodes JM, Davies MG, Lyden SP, Green RM. EEG changes during awake carotid endarterectomy, Ann Vasc Surg 2002; 16:6-11.

  Tanski WJ, Roztocil E, Davies MG. Sphingosine-1-phosphate induces Gαi coupled, PI3-kinase-dependent smooth muscle cell migration. J Surg Res 2002; 108: 98-106.

  Fegley AJ, Tanski WJ, Roztocil E, Davies MG. Sphingosine-1-phosphate stimulates smooth muscle cell migration through Gαi- and PI3-kinase-dependent p38MAPK activation. J Surg Res 2003; 113:32-41.

  Surowiec SM, Sivamurthy N, Rhodes JM, Lee D, Green RM, Waldman DL, Davies MG. Longterm outcomes after percutaneous therapy for renal artery FMD. Ann Vasc Surg 2003; 17:650-655.

  DaiQ, SilversteinAD, Davies MG, Hagen P-O, Donatucci CF, AnnexBH. Systemic basic fibroblast growth factor induces favorable histological changes in the corpus cavernosum of hypercholesterolemic rabbits. J Urol 2003; 170:664-668.

  Illig KA, Zhang R, Sternbach Y, Shortell C, Rhodes JM, Davies MG, Ouriel K, Tanski WJ, Green RM. Carotid Endarterectomy: Then and Now. Surgery 2003; 134:705-11.

  Green RM, Waldman, DL and Center for Vascular Disease (Davies MG, Illig KA, Rhodes JR, Shortell C, Sternbach Y, Lee D, Sahler L). Five year Results of a merger between Vascular Surgeons and Interventional Radiologists in a University Medical Center. J Vasc Surg 2004; 38:1213-9.

  Tanski WJ, Fegley AJ, Roztocil E, Davies MG. Domain dependent actions of urokinase (sc-uPA) on smooth muscle cell response to injury. J Vasc Surg 2004; 39:214-22.

  Sivamurthy N, Surowiec SM, Rhodes JM, Sternbach Y, Lee D, Green RM, Waldman DL, Davies MG, Divergent outcomes after percutaneous therapy in renal artery stenosis. J Vasc Surg 2004; 39:565-574.

  Surowiec SM, Fegley AJ, Tanski WJ, Sivamurthy N, Illig KA, Lee D, Waldman DL, Green RM, Davies MG. Endovascular management of central venous stenoses in the hemodialysis patient: an update. Vasc Endovasc Surg 2004; 38:349-54.

  Englesbe MJ, Davies MG, Hawkins SM Hsieh PCH, Daum G, Kenagy RD. Clowes AW. Arterial injury repair in non-human primates – the role of PDGF receptor-β. J Surg Res 2004;119(1):80-4.

  Surowiec SM, Davies MG, Fegley AJ, Tanski WJ, Pamoukian VN, Sternbach Y, Waldman DL, Green RM. The relationship of proximal fixation to postoperative renal dysfunction in patients with normal serum creatinine J Vasc Surg 2004; 39:804-810.

  Tanski WJ, Roztocil E, Hernady E, Williams JP, Davies MG. Role of Gαq in smooth muscle cell proliferation. J Vasc Surg 2004; 39: 639-644.

  Galaria II, Fegley AJ, Nicholl SM, Roztocil E, Davies MG. Differential regulation of ERK1/2 and p38MAPK by components of the rho signaling pathway during sphingosine-1-phosphate-induced smooth muscle cell migration. J Surg Res 2004; 122: 173-179.

  Hsu J, Surowiec SM, Davies MG, Rhodes JM, Shortell CK, Lee D, Waldman DL, Green RM. Illig KA. Validation of endovascular skills using computer-based simulation. J Vasc Surg 2004; 40:1118-1125.

  Galaria II, Surowiec SM, Davies MG. Combined endovascular and open approach in renal salvage for acute renal artery in-stent thrombosis. the dangers of undiagnosed Takayasu’s Disease. Eur J Vasc Endovasc Surg 2004; 28:674-6.

  Keefer A, Davies MG, Illig KA. Can endovascular therapy of infra-inguinal disease for claudication be justified? Expert Review Cardiovasc Ther 2004; 229-237.

  Illig KA, Alkon JE, Smith A, Rhodes JM, Keefer A, Doyle A, Serletti J, Shortell CS, Davies MG, Green RM. Rotational muscle flap for acute groin wound infection following vascular surgery. Ann Vasc Surg 2004; 18:661-668.

  Galaria II, Davies MG. Percutaneous transluminal revascularization for iliac occlusive disease: long-term outcomes in TASC A and B lesions. Ann Vasc Surg 2005; 19:352-360.

  Galaria II, Surowiec SM, Davies MG. Endovascular control of a ruptured proximal SMA pseudoaneurysm due to polyarteritis nodosa. Eur J Vasc Endovasc Surg - EJVES Extra 2005; 29:555.

  Nicholl SM, Roztocil E, Davies MG. Differential MAPK activation controls urokinase-induced smooth muscle cell responses: a role for the epidermal growth factor receptor. J Vasc Surg 2005; 41:672-81.

  Saad WEA, Saad NE, Davies MG, Lee DE, Sahler L, Patel N, Waldman DL. Transhepatic balloon dilation of anastomotic biliary strictures in liver transplant recipients: the significance of a patent hepatic artery. J Vasc Intervent Radiol 2005; 16:1221-8.

  Saad WEA, Davies MG, Sahler L, Lee DE, Patel NC, Kitanosono T, Sasson T, Waldman DL. Hepatic artery stenosis in liver transplant receipients: primary treatment with PTA. J Vasc Intervent Radiol 2005; 16:795-805.

  Wolford HY, Surowiec SM, Hsu J, Illig KA, Rhodes JM, Shortell C, Lee D, Waldman DL, Green RM Davies MG, Use of Stacked Zenith Proximal Cuffs to Treat Focal Thoracic Aortic Pathology in High-Risk Patients. J Endovasc Ther 2005; 12:574-578.

  Illig KA, Surowiec SM, Shortell CK, Davies MG, Rhodes JM, Green RM. Hemodynamics of Distal Revascularization-Interval Ligation (DRIL). Ann Vasc Surg 2005; 19: 199-207.

  Galaria II, Surowiec SM, Tanski WJ, Fegley AJ, Rhodes JM, Illig KA, Shortell CK, Green RM, Davies MG. Popliteal to Distal Bypass: Identifying Risk Factors Associated with Limb Loss and Graft Failure. Vasc Endovasc Surg 2005; 39:393-400.

  Tanski WJ, Nicholl S, Kim D, Roztocil E, Davies MG. Sphingosine-1-phosphate-induced smooth muscle cell migration involves the Mammalian Target of Rapamycin. J Vasc Surg 2005; 41:91-98.

  Surowiec SM, Davies MG, Lee D, Illig KA, Rhodes JM, Shortell CK, Waldman DL, Green RM, Percutaneous angioplasty and stenting of the superficial femoral artery. J Vasc Surg 2005; 41:269-278.

  Nicholl SM, Roztocil E, Galaria II, Davies MG. Plasmin induces smooth muscle cell proliferation through Gαi- and Gαq- mediated pathways. J Surg Res 2005; 127: 39-45.

  Galaria II, Nicholl SM, Roztocil E, Davies MG. Urokinase-induced smooth muscle cell migration requires both PI3K / akt and PI3K / ERK1/2 activation. J Surg Res 2005; 127: 46-52.

  Galaria II, Surowiec SM, Rhodes JM, Illig KA, Shortell CK, Davies MG. Percutaneous and open renal revascularization have equivalent long-term functional outcomes. Ann Vasc Surg 2005; 19: 218-228.

  Saad WEA, Davies MG, Sahler LG, Lee DE, Patel N, Sassoon T, Waldman DL. Arc of Buhler: incidence and diameter in asymptomatic individuals. Vasc Endovasc Surg 2005; 39:347-9.

  Roztocil E, Nicholl SM, Galaria II, Davies MG. Plasmin induced smooth muscle cell proliferation requires epidermal growth factor activation. Surgery 2005; 138:180-6.

  Saad N, Saad WEA, Davies MG, Waldman DL, Fultz PJ, Rubens D. Pseudo-aneurysms and the role of minimally invasive techniques in their management. Radiographics 2005; 25 (suppl 1):S173-190.

  Saad WEA, Davies MG, Sahler LG, Lee DE, Patel NC, Kitanosono T, Sasson T, Waldman DL. Transjugular intrahepatic porto-systemic shunt in a living donor left lateral segment liver transplant recipient: technical considerations. J Vasc Intervent Radiol 2005; 16:873-7.

  Davies MG, Waldman DL, Pearson TA. Comprehensive endovascular therapy for femoropopliteal arterial atherosclerotic occlusive disease. J Am Coll Surg 2005: 201:275-296.

  Wolford HY, Hsu J, Rhodes JM, Shortell CK, Davies MG, Bakhru A, Illig KA, Outcome of Autologous Upper Arm Brachio-Basilic Transposition in the Post-DOQI Era. J Vasc Surg 2005; 42:951-956.

  Galaria II, Surowiec SM, Rhodes JM, Illig KA, Shortell CK, Davies MG. Implications of early failure of superficial femoral artery endoluminal interventions. Ann Vasc Surg 2005; 19:1-7.

  Wolford HY, Surowiec SM, Davies MG. SFA angioplasty versus femoro-popliteal bypass: what is the goal and where is the endpoint? Endovascular Today 2005; 4(6):51-53.

  Davies MG, Waldman DL. Fibromuscular dysplasia: catheter, cut or laissez faire? That remains the question. J Human Hypertension 2005; 10: 755-6.

  Nicholl SM, Roztocil E, Davies MG. Plasminogen Activator System and Vascular Disease. Curr Vasc Pharmacol 2006; 2006; 4(2):101-16.

  Sivamurthy N, Rhodes JM, Lee D, Waldman DL, Green RM, Davies MG. Endovascular versus open mesenteric revascularization: immediate benefits do not equate with short-term functional outcomes. J Am Coll Surg 2006; 202(6):859-67.

  Saad WEA, Davies MG, Saad NE, Waldman DL, Sahler LG, Lee DE, Kitanosono T, Sasson T, Patel NC. Transhepatic dilation of anastomotic biliary strictures in liver transplant recipients with use of a combined cutting and conventional balloon protocol: technical safety and efficacy. J Vasc Intervent Radiol 2006; 17:837-43.

  Saad WE, Saad NE, Davies MG, Bozorgdadeh A, Orloff MS, Patel NC, Abt PL, Lee DE, Sahler LG, Kitanosono T, Sasson T, Waldman DL. Elective transjugular intrahepatic portosystemic shunt creation for portal decompression in the immediate pretransplantation period in adult living related liver transplant recipient candidates: preliminary results. J Vasc Intervent Radiol 2006; 17(6): 995-1002.

  Saad WEA, Virdee S, Davies MG, Patel NC, Sahler LG, Lee DE, Kitanosono T, Sasson T, Wilson IJ, Waldman DL. Inadvertent discontinuation of percutaneous nephrostomy catheters in adult native kidneys: prevalence and percutaneous management. J Vasc Intervent Radiol 2006; 17: 1457-64.

  Saad WE, Ryan CK, Davies MG, Fultz P, Rubens DJ, Patel NC, Sahler LG, Lee DE, Kitanosono T, Sasson T, Waldman DL. Safety and efficacy of fluoroscopic versus ultrasound guided core liver biopsies for potential live liver transplant donors. J Vasc Intervent Radiol 2006; 17: 1307-12.

  Saad WEA, Davies MG, Lee DE, Sahler L, Patel N, Waldman DL. Incidence of arterial injuries detected by arteriography following percutaneous right-lobe ultrasound-guided core liver biopsies in human subjects. Am J Gastroenterol 2006; 101(11):2641-5.

  Saad WEA, Davies MG, Reubens D, Sahler LG, Lee DE, Patel NC, Waldman DL. Endoluminal Management of Arterio-Portal Fistulae in Liver Transplant Recipients: A Single Center Experience. Vasc Endovasc Surg 2007; 40(6):451-9.

  Protack CD, Bakken AM, Saad WEA, Illig KA, Waldman DL, Davies MG. Radiation arteritis: a contraindication to carotid stenting? J Vasc Surg 2007; 45(1):110-7.

  Saad WEA, Davies MG, Lee DE, Sahler L, Patel N, Waldman DL. Catheter thrombolysis of thrombosed hepatic arteries in liver transplant recipients: predictors of success and role of thrombolysis. Vasc Endovasc Surg 2007; 41: 19-26.

  Palchik E, Bakken AM, Saad N, Saad WEA, Davies MG. Endovascular treatment of tracheo-innominate artery fistula. Vasc Endovasc Surg 2007; 41: 258-261.

  Bakken AM, Protack CD, Saad WEA, Lee D, Waldman DL, Davies MG. Longterm outcomes of primary angioplasty versus primary stenting in the management of central venous stenoses in the hemodialysis patient. J Vasc Surg 2007; 45:776-83.

  Saad NE, Pegoli W, Alfieres G, Waldman DL, Davies MG. Endovascular repair of a traumatic aortic transsection in a pediatric patient. J Vasc Intervent Radiol 2007; 18:443-6.

  Protack CD, Bakken AM, Patel N, Saad WEA, Waldman DL, Davies MG, Long term outcomes of catheter directed thrombolysis for iliofemoral DVT without universal prophylactic IVC filter placement J Vasc Surg 2007; 45(5):992-7.

  Saad N, Briones AJ, Rhodes JR, Boyce B, Waldman DL, Davies MG. Pseudoaneurysm of a genicular branch of the popliteal artery and deep venous thrombosis: an unusual presentation of an osteochondroma. J Vasc Intervent Radiol 2007;18(4):581-3.

  Bakken AM, Galaria II, Agerstand C, Saad WE, Surowiec SM, Singh MJ, Rhodes JM, Lee S, Patel NC, Illig KA, Waldman DL, Davies MG. Percutaneous therapy to maintain dialysis access successfully prolongs functional duration after primary failure. Ann Vasc Surg 2007; 2007; 21:474-480.

  Bakken AM Protack CD, Waldman DL, Davies MG. Hybrid debranching-Endovascular Repair of Visceral Patch Aneurysm after Thoracoabdominal Aneurysm Repair. Vasc Endovasc Surg 2007; 41:249-253.

  Roztocil E, Nicholl SM, Davies MG. Mechanisms of Kringle Fragment of Urokinase induced Vascular Smooth Muscle Cell Migration. J Surg Res 2007; 141: 83-90. PMC2048815.

  Zou Y, Qi Y, Roztocil E, Nicholl SM, Davies MG. Patterns of Kinase activation induced by injury in the murine femoral artery. J Surg Res 2007; 141: 332-340. PMC2048817.

  Bakken AM, Palchik E, Hart JP, Rhodes JM, Saad WEA, Davies MG. Impact of diabetes on outcomes of superficial femoral artery endoluminal interventions. J Vasc Surg 2007; 46:946-958.

  Roztocil E, Nicholl SM, Davies MG. S-1-P induced VSMC migration via activation of NAD(P)H oxidase requires Gα12/13 protein mediated phospholipase C activation. J Vasc Surg 2007; 46: 1253-1259. PMC2607047.

  Doyle A, Wolford HY, Davies MG, Adams JT, Singh MJ, Saad W, DeWeese JA, Waldman DL, Illig KA. Management of spontaneous subclavian vein thrombosis in the thrombolytic era. Ann Vasc Surg 2007; 21:723-9.

  Tomlinson J, McNamara JM, Matloubieh J, Hart J, Singh MJ, Davies MG, Rhodes JM, Illig KA. Immediate follow-up after EVAR: Can we forgo CT scanning in certain patients? Ann Vasc Surg 2007; 21:663-70.

  Palchik E, Bakken AM, Saad WEA, Wolford HY, Davies MG. Subclavian artery revascularization: an outcome analysis based on mode of therapy and presenting symptoms. Ann Vasc Surg 2008; 22: 70-80.

  Bakken AM, Saad WEA, Davies MG. Cryo balloon angioplasty broadens the role of primary angioplasty and reduces adjuvant stenting in complex superficial femoral artery (TASC C and D) lesion. J Am Coll Surg 2008; 206(3):524-32.

  Lee RW, Rhodes JM, Singh MJ, Davies MG, Wolford HY, Diachun C, Norton R, Illig KA. Is there a selection bias in applying EVAR for rupture? Ann Vasc Surg 2008; 22: 215-20.

  Bakken AM Palchik E, Saad WE, Waldman DL, Davies MG, Longterm outcomes of endoluminal therapy for ostial disease of the major branches of the aortic arch. Ann Vasc Surg 2008; 22: 388-394.

  Palchik E, Bakken AM, Wolford HY, Waldman DL, Davies MG. Evolving strategies in treatment of symptomatic isolated innominate artery disease. Vasc Endovasc Surg 2008; 42(5):440-5.

  Lee, RW, Bakken, AM, Palchik E, Saad WE, Davies MG. Longterm outcomes of endoluminal therapy for chronic atherosclerotic occlusive mesenteric disease. Ann Vasc Surg 2008; 22: 541-6.

  Saad N, Saad WEA, Davies MG, Waldman DL. Replacement of inadvertently discontinued tunneled jugular high-flow central catheters utilizing tract recannulation: Technical results and outcome. J Vasc Intervent Radiol 2008;19(6):890-6.

  Roztocil E, Nicholl SM, Davies MG. Insulin induced Epidermal Growth Factor Receptor transactivation in smooth muscle cells is ADAM-dependent. Surgery 2008; 144(2):245-51. PMC18656632.

  Davies MG, Saad WE, Peden EK, Mohiuddin IT, Naoum JJ, Lumsden AB. Impact of runoff on superficial femoral artery endoluminal interventions for Rest Pain and Tissue Loss. J Vasc Surg 2008; 48(3):619-25.

  Davies MG, Saad WE, Peden EK, Mohiuddin IT, Naoum JJ, Lumsden AB. Percutaneous superficial femoral artery interventions for claudication--does runoff matter? Ann Vasc Surg 2008: 22(6):790-8.

  Davies MG, Saad WE, Peden EK, Naoum JJ, Mohiuddin IT, Lumsden AB. The long-term outcomes of Percutaneous Therapy for Renal Artery Fibromuscular Dysplasia. J Vasc Surg 2008: 48; 865-871.

  Davies MG, Saad WE, Peden EK, Mohiuddin IT, Naoum JJ, Lumsden AB. Implications of acute renal injury following percutaneous renal artery intervention. Ann Vasc Surg 2008: 22(6):783-9.

  Karmonik C, Bismuth, JX, Davies MG, Lumsden AB. Computational Hemodynamics in the Human Aorta: a Computational Fluid Dynamics Study of Three Cases with Patient-Specific Geometries and Inflow Rates. Technol Health Care 2008: 16(5): 343-354.

  Zou Y, Qi Y, Roztocil E, Nicholl SM, Lumsden AB, Davies MG. Patterns of gelatinase activation induced by injury in the murine femoral artery. J Surg Res 2009: 54(1):135-42. . PMC2698815.

  Garami ZP, Bismuth J, Charlton-Ouw K, Davies MG, Peden EK, Lumsden AB. The feasability of imultaneous pre- and post-filter transcranial doppler monitoring during carotid artery stenting J Vasc Surg 2009; 49(2): 340-345.

  Bakken AM, Protack CD, Saad WE, Rhodes JR, Hart JP, Waldman DL, Davies MG. Impact of Chronic Kidney Disease on Outcomes of Superficial Femoral Artery Endoluminal Interventions Ann Vasc Surg 2009: 23(5):560-8.

  Protack CD Bakken AM, Xu J, Saad WE, Lumsden AB, Davies MG. Metabolic Syndrome: a predictor of adverse events after Carotid Revascularization J Vasc Surg 2009: 49:1172-80.

  Davies MG, Saad WE, Bismuth J, Peden EK, Naoum JJ, Lumsden AB. Outcomes of Endoluminal Re-Intervention for Restenosis after Percutaneous Renal Angioplasty and Stenting. J Vasc Surg 2009: 49:946-52.

  Davies MG, Saad WE, Bismuth J, Peden EK, Naoum JJ, Lumsden AB. Endovascular Revascularization Of Renal Artery Stenosis In The Solitary Functioning Kidney. J Vasc Surg 2009: 49:953-60.

  Roztocil E, Nicholl SM, Davies MG. Mechanisms of sphingosine-1-phosphate-induced akt-dependent smooth muscle cell migration. Surgery 2009; 145:34-41. PMC2676383.

  Bakken AM, Protack CD, Roztocil E, Nicholl SM, Davies MG. Cell Migration In response to the Aminoterminal Fragment Of Urokinase Requires Epidermal Growth Factor Receptor Activation Through An ADAM-mediated Mechanism J Vasc Surg 2009; 49:1296-1303. PMC2691776.

  Lumsden AB, Davies MG, Peden EK. Medical and Endovascular Management of Critical Limb Ischemia. J Endovasc Ther 2009;16(supplII): II-31-II-62.

  Ginat DT, Saad WEA, Waldman DL, Davies MG. Stent-Graft Placement for Management of Iatrogenic Hepatic Artery Branch Pseudoaneurysm after Liver Transplantation. Vasc Endovasc Surg 2009; 43 (5): 513-7.

  Ginat DT, Saad WEA, Davies MG, Waldman Dl, Ertuk E. Bowel Displacement For CT-Guided Tumor Radiofrequency Ablation: Techniques And Anatomical Considerations. J Endourol 2009; 23(8): 1259-64.

  Saad WEA, Wilson IJ, Davies MG, Westesson KE, Darwish WM, Waldman DL. Intravenous Morphine for Augmentation of Postoperative T-Tube Cholangiograms in Liver Transplant Recipients with Choledocho-Choledochal Anastomoses. J Vasc Interv Radiol 2009; 20(10):1320-8.

  SVS Task Force on Comparative Effectiveness (Stoner M, Davies MG, Forbes T, Meissner M, LoGerfo F). Comparative Effectiveness Research in Vascular Interventions. J Vasc Surg 2009; 49(6):1592-1593.

  Karmoniak C, Bismuth J, Davies MG, Younes HK, Lumsden AB. Computational fluid dynamics as a tool for visualizing hemodynamic flow patterns. Methodist DeBakey Cardiovascular Journal 2009; 5(3):26-31.

  Reardon MJ, Davies MG. Central Venous Stenosis - Endovascular and Surgical treatment. Methodist DeBakey Cardiovascular Journal 2009; 5(4): 32-35.

  Davies MG. Overview of Venous Disease. Methodist DeBakey Cardiovascular Journal 2009; 5(4): 5-6.

  Davies MG. Deep Venous Thrombosis: Prevention and Treatment. Methodist DeBakey Cardiovascular Journal 2009; 5(4): 25-31.

  Davies MG, Bismuth J. Arteriovenous malformations - Diagnosis and Treatment. Methodist DeBakey Cardiovascular Journal 2009; 5(4): 41-47.

  Karmonik C, Bismuth J, Davies MG, Younes HK, Lumsden AB. An Image Processing Algorithm for the In-vivo Quantification and visualization of septum motion in type III B - aortic dissections with cine magnetic resonance imaging. Conf Proc IEEE Eng Med Biol Soc 2009; 1: 4391-4.

  Davies MG, Bismuth J, Saad WE, Naoum JJ, Peden EK, Lumsden AB. Implications of in situ thrombosis and distal embolization during superficial femoral artery endoluminal intervention. Ann Vasc Surg 2010; 24(1):14-22.

  Broadbent K, Hodge M, Votour C, Garami Z, Davies MG. Duplex Assessment of carotid body tumor. Ultrasound Today 2009; 14(6):97-120.

  Saad WE, Darwish WM, Davies MG, Waldman DL. Transjugular Intrahepatic Portosystemic Shunts in Liver Transplant Recipients for Management of Refractory Ascites: Clinical Outcome. J Vasc Interv Radiol 2010; 21(2):218-23.

  Younes HK, Davies MG, Bismuth J, Naoum JJ, Peden EK, Reardon MJ, Lumsden AB. Hybrid thoracic endovascular aortic repair (TEVAR): Pushing the envelope? J Vasc Surg 2010; 51(1): 259-266.

  Davies MG, Bismuth J, Saad WE, Naoum JJ, Peden EK, Lumsden AB Renal parenchymal preservation after percutaneous renal angioplasty and stenting. J Vasc Surg 2010: 51(5):1222-9.

  Protack CD, Bakken AM, Saad WE, Davies MG. Renal artery interventions during EVAR: a greater potential of subsequent failure? J Vasc Intervent Radiol 2010: 21(4): 459-64.

  Davies MG, Bismuth J, Saad WE, Naoum JJ, Peden EK, Lumsden AB. Impact of metabolic syndrome on the outcomes of percutaneous renal angioplasty and stenting. J Vasc Surg 2010: 51:926-32.

  Younes HK, Harris PW, Bismuth J, Charlton-Ouw K, Peden EK, Lumsden AB, Davies MG. Thoracic Endovascular Aortic Repair for Type B Aortic Dissection. Ann Vasc Surg 2010: 24(1):39-43.

  Kaiser CL, Anaya-Ayala JE, Ismail N, Davies MG, Peden EK. Unrecognized basilic vein variation leading to complication during basilic vein transposition arteriovenous fistula creation: Case report and implications for access planning. Eur J Vasc Endovasc Surg 2010 39(5):627-9.

  Anaya-Ayala JE Harris PW, Younes, HK, Charlton-Ouw K, Bismuth JX, Davies MG, Peden EK, Lumsden AB. Spontaneous Regression of an Abdominal Aortic Aneurysm in an Immunocompromised Patient. Vasc Med 2010:15:315-9.

  Vykoukal D, Davies MG. Stent Grafting in the Superficial Femoral Artery. Ital J Vasc Endo Surg 2010: 17:23-30.

  Davies MG, Bismuth J, Saad WE, Naoum JJ, Peden EK, Lumsden AB. Outcomes of Interventions for Recurrent Disease after Endoluminal Intervention for Superficial Femoral Artery Disease. J Vasc Surg 2010: 52:331-9.

  Saad WE, Darwish WM, Davies MG, Waldman DL. Stent-Grafts for Transjugular Intrahepatic Portosystemic Shunt Creation: Specialized bare-covered stent for TIPS Versus a combination of a multipurpose stent-graft and a multipurpose bare-stent. J Vasc Interv Radiol 2010; 21(10):1512-20.

  Bismuth J, Donovan M, O’Malley M, Naoum JJ, ElSayad H, Peden EK, Davies MG, Lumsden AB. Incorporating simulation in vascular surgery education. J Vasc Surg 2010; 52(4):1072-80.

  Karmonik C, Bismuth J, Redel T, Anaya-Ayala JE, Davies MG, Lumsden AB. Impact of Tear Location on Hemodynamics in a Type B Aortic Dissection investigated with Computational Fluid Dynamics. Conf Proc IEEE Eng Med Biol Soc. 2010;1:3138-41.

  Lumsden AB, Anaya-Ayala JE, Bismuth J, Davies MG. Successful Robot-assisted Pulmonary Artery Stenting of high grade anastomotic artery stenosis following Single Lung Transplantation. J Endovasc Ther 2010; 17(5):612-6.

  Davies MG, Younes HK, Harris PW, Masud F, Croft BA, Reardon MJ, Lumsden AB Outcomes after initiation of an Acute Aortic Treatment Center. J Vasc Surg 2010; 52:1478-85.

  Bellows PH, Anaya-Ayala JE Cheema ZF, Davies MG, Lumsden AB, Peden EK. Combined Femoral Vein Transposition Arteriovenous Fistula and Iliac Vein to Suprarenal Inferior Vena Cava Bypass as a last resort Dialysis Access. Ann Vasc Surg 2011: 25(2):264.e5-8.

  Younes HK, Pettigrew CD, Anaya-Ayala JE, Soltes G, Saad WE, Davies MG, Lumsden AB, Peden EK. Transhepatic hemodialysis catheters: functional outcome and comparison between early and late failure. J Vasc Intervent Radiol 2011;22(2):183-91.

  Zaporteza K, Anaya-Ayala JE, Davies MG, Peden EK, Lumsden AB. Recurrent collapse of a Gore TAG Endograft in treating an aortoesophageal Fistula. Vascular 2011; 19(3):154-8.

  Ginat DT, Saad WE, Davies MG, Waldman DL, Kitanosono T. Incidence of cholangitis & sepsis associated with percutaneous transhepatic biliary drain cholangiography & exchange: A comparison between liver transplant & native liver patients. AJR Am J Roentgenol 2011; 196(1):W73-W77.

  Yeniaras E, Deng Z, Syed MA, Davies MG, Tsekos NV. A Novel Virtual Reality Environment for Preoperative Planning and Simulation of Image Guided Intracardiac Surgeries with Robotic Manipulators. Stud Health Technol Inform 2011; 163: 716-722.

  Davies MG, Bismuth J, Saad WE, Naoum JJ, Peden EK, Lumsden AB. Outcomes of endoluminal re-intervention for recurrent disease after percutaneous iliac angioplasty and stenting. J Endovasc Ther 2011;18(2):169-80.

  Bismuth J, Garami Z, Anaya-Ayala JE, Naoum JJ, Peden EK, Lumsden AB. Davies MG. Cerebral embolization during thoracic endovascular aortic repair: Role of Transcranial Doppler Monitoring. J Vasc Surg 2011; 54(2):364-9.

  Karmonik C, Bismuth J, Shah D, Davies MG, Younnes HK, Lumsden AB. A computational fluid dynamics study pre- and post-stent graft placement in type B aortic dissections. Vasc Endovasc Surg 2011; 45(2):157-64.

  Anaya-Ayala JE, Cheema ZF, Johnson B, Naoum JJ, Ramlawi B, Davies MG, Bismuth J, Peden EK, Lumsden AB, Reardon MJ. Hybrid thoracic endovascular aortic repair via right anterior minithoracotomy J Thor Cardiovasc Surg 2011 142(2):314-8.

  Anaya-Ayala JE, Bellows PH, Gonzales-Morales S, Cheema ZF, Naoum JJ, Bismuth J, Davies MG, Lumsden AB, Peden EK. Surgical management of hemodialysis-related central venous occlusive disease: a treatment algorithm. Ann Vasc Surg 2011:25(1):108-19.

  Smolock CJ, Chen G, Anaya-Ayala, JE, Martinez K, Lumsden AB, Davies MG, Naoum, JJ, Peden EK. Successful Endovascular Repair of two Ruptured Thoracic Aortic Aneurysms in Nonagenarians. Ann Vasc Surg 2011; 25(5):697.e9-697.e12.

  Lumsden AB, Davies MG. Aortic disease – the evolving therapeutic challenge. Methodist DeBakey Cardiovascular Journal 2011; 7(3): 1.

  Davies MG, Anaya-Ayala JE, Lumsden AB. Fenestrated and branched endografts. Methodist DeBakey Cardiovascular Journal 2011; 7(3): 35-38.

  Davies MG, Lumsden AB. Acute Aortic Treatment Center. Methodist DeBakey Cardiovascular Journal 2011; 7(3): 8-10.

  Fernandez J, Vykoukal D, Davies MG. Biology of Aortic Aneurysms and Dissections. Methodist DeBakey Cardiovascular Journal 2011; 7(3): 2-7.

  Naoum JJ, Reardon MJ, Davies MG. Changing paradigm in endovascular treatment of descending thoracic aortic dissections Methodist DeBakey Cardiovascular Journal 2011; 7(3): 25-27.

  Vykoukal D, Davies MG. The biology of metabolic syndrome. J Vasc Surg 2011: 54:819-31 PMC3136643.

  Davies MG, Hagen PO. Reprinted "Pathophysiology of vein graft failure: a review". Eur J Vasc Endovasc Surg. 2011 Sep;42 Suppl 1:S19-29.

  Vykoukal D, Davies MG. Metabolic syndrome and outcomes after renal intervention. Cardiol Res Pract 2011:781035 PMC3014711.

  Anaya-Ayala JE, Younes HK, Kaiser CL, Syed O, Ismail N; Naoum JJ, Davies MG, Peden EK. Prevalence of variant brachial-basilic vein anatomy and implications for vascular access planning: An observational study using Duplex ultrasound mapping. J Vasc Surg 2011; 53(3):720-4.

  Anaya-Ayala JE, Obilom C, Cheema ZF, Naoum JJ, Bismuth J, Davies MG, Lumsden AB, Peden EK. Clinical outcomes with covered stent placement for central venous occlusive disease in hemodialysis patients. J Vasc Surg 2011; 54(3):754-9.

  Bavare C, Kim M, Blackmon S, Ellsworth W, Davies MG, Reardon MJ. Delayed aortic rupture after aortic endograft placement in a patient with spinal hardware. Ann Thor Surg 2011; 2011; 92(4):1512-4.

  Anaya-Ayala JE, Johnson B, Smolock CJ, Davies MG, Peden EK. Inferior Vena Cava bypass for the treatment of obliterative hepatocavopathy with 5 year Follow-up. Vascular 2011: 19(5):282-6.

  Protack CD, Bakken, AM, Saad WE, Davies MG. Influence of chronic renal insufficiency on outcomes following carotid revascularization. Arch Surg 2011;146(10):1135-1141.

  Partovi S, Loebe M, Noon GP, Davies MG, Karimi S, Zipp L, Feinstein SB, Staub D. Detection of Adventitia l Vasa Vasorum and Intraplaque Neova scularization in Carotid Atherosclerotic Lesions with Contrast-Enhanced Ultrasound and Their Role in Atherosclerosis. Methodist DeBakey Cardiovascular Journal 2011; 7(4): 37-40.

  Cheema ZF, Davies MG, Walton, B, Reardon MJ, Lumsden AB. Hybrid imaging to facilitate accurate placement of a TEVAR prior to completion esophagectomy. J Vasc Surg 2011; 54:1501.

  Karmonik C, Duran C, Davies MG, Shah DJ, Lumsden AB, Bismuth J. Correlation between hemodynamic parameters and intra-arterial septum motion in DeBakey type III aortic dissections using 2D pcMRI and 4D MRA. Conf Proc IEEE Eng Med Biol Soc. 2011: 2011; 2809-12.

  Karmonik C, Bismuth J, Davies MG, Shah DJ, Anaya-Ayala JE, Purdy D, Lumsden AB. Computational Study of Haemodynamic Effects of Entry and Exit Tear Coverage in a DeBakey Type III Aortic Dissection: Technical Report. Eur J Vasc Endovasc Surg 2011; 42(2):172-7.

  Colvard BD, Anaya-Ayala JE, Palacios-Reyes D, Cheema ZF, Smolock CJ, Davies MG, Peden EK. Increasing Hemodialysis Access Options in the lower extremity: Retroperitoneal approach for external iliac artery to external iliac vein arteriovenous graft. J Vasc Access 2011; 12(4):365-8.

  Younes HK, Broadbent K, Hodge M, Arredondo S, Bismuth J, Davies MG, Lumsden AB. Inferior mesenteric artery duplex in the management of chronic mesenteric ischemia. J Vasc Ultrasound 2011;35(3):153-157.

  Peden EK, Chen GJ, Anaya-Ayala JE, Ismail N, Smolock CJ, Davies MG. Successful use of the HeRO device to salvage a functional arteriovenous access and resolve symptoms of venous hypertension. EJVES Extra 2011; 22(4):e37-e39.

  Anaya-Ayala JE, Pettigrew CD, Ismail N, Diez-De Sollano AL, Syed FA, Ahmed FG, Davies MG, Peden EK Management of dialysis access-associated "Steal" Syndrome with DRIL Procedure: Challenges and clinical outcomes. J Vasc Access 2011; 13(3):299-304.

  Davies MG. Three-Year Outcomes of the RESILIENT Trial: Are They Enough to Support a Primary Stenting Policy? J Endo Vasc Ther 2012; 19(1):10-11.

  Anaya-Ayala JE, Davies MG, Reardon MJ. Concomitant reconstruction of infrarenal aorta and inferior vena cava after en bloc resection of retroperitoneal rhabdomyosarcoma. Vasc Endovasc Surg 2012; 45(8):769-72.

  Smolock CJ, Davies MG, Anaya Ayala J, Bismuth J, ElSayad HE, Naoum JJ, Peden EK, Lumsden AB. Impact of Metabolic syndrome on SFA interventions. J Vasc Surg 2012; 55:985-93.

  Anaya-Ayala JE, Chen G, Davies MG, Lumsden AB. Technological Devices in Peripheral Percutaneous Interventions. Minerva Cardiol 2012; 60(2):237-55.

  Duru EA, Fu Y, Davies MG. src regulates Sphingosine-1-Phosphate mediated smooth muscle cell migration. J Surg Res 2012; 175: 30–34 PMC3242881.

  Telich-Tarriba JE, Anaya-Ayala JE, Davies MG, ElSayad HE. Percutaneous mechanical thrombectomy for extensive acute lower extremity deep venous thrombosis in a patient following double-lung transplantation. Ann Vasc Surg 2012; 26(4):573.e1-4.

  Adams MK, Anaya-Ayala JE, Davies MG, Bismuth J, Peden EK Endovascular management of iliac vein rupture during percutaneous interventions for occlusive lesions. Ann Vasc Surg 2012; 26(4):575.e5-9.

  Jacobi B, Bongartz G, Partovi S, Schulte AC, Aschwanden M, Lumsden AB, Davies MG, Loebe M, Noon GP, Karimi S, Lyo JK, Staub D, Huegli RW, Bilecen DSkeletal muscle BOLD MRI: From underlying physiological concepts to its usefulness in clinical conditions J Mag Res Imag 2012; 35(6):1253-65.

  Karmonik C, Duran C, Shah D, Anaya-Ayala JE, Davies MG, Lumsden AB, Bismuth J. Preliminary Findings in Quantification of Changes in Septal Motion During Follow-Up of Type B Aortic Dissections. J Vasc Surg 2012; 55: 1419-1426.e1.

  Vykoukal D, Davies MG. Biology of metabolic syndrome in a vascular patient. Vascular 2012; 20(3):156-65.

  Colvard B, Anaya-Ayala JE, Smolock CJ, Reardon MJ, Davies MG. Segmental Endovascular exclusion to avoid aortic cross clamping and facilitate removal of an errant intravascular pedicle spinal fixation screw. J Vasc Surg 2012; 56:201-4.

  Syed FA, Smolock CJ, Anaya-Ayala JE, Cheema ZF, Syed O, Naoum JJ, Hyunh TT, Peden EK, Davies MG.Comparison of outcomes of one staged transpositions and two stage basilic vein transpositions. Ann Vasc Surg 2012; 26(6):852-7.

  Partovi S, Schulte AC, Jacobi B, Klarhöfer M, Lumsden AB, Loebe M, Davies MG, Noon GP, Karmonik C, Zipp L, Bongartz G, Bilecen D. Blood oxygenation level-dependent (BOLD) MRI of human skeletal muscle at 1.5 and 3 T. J Magn Reson Imaging. 2012;35(5):1227-32.

  Karmonik C, Partovi S, Müller-Eschner M, Bismuth J, Davies MG, Shah DJ, Loebe M, Böckler D, Lumsden AB, von Tengg-Kobligk H. Longitudinal computational fluid dynamics study of aneurysmal dilatation in a chronic DeBakey type III aortic dissection. J Vasc Surg. 2012 Jul;56(1):260-263.e1.

  Bismuth J, Duran C, Donovan M, Davies MG, Lumsden AB. The Cardiovascular Fellows Bootcamp. J Vasc Surg. 2012 ;56(4):1155-1161. e1.

  Zou Y, Fu Y, Duru EA, Davies MG. Role for Gβγ G-proteins in protease regulation durng remodeling of the murine femoral artery. J Surg Res 2012; 178(1):40-7 PMC3251654.

  Duru EA, Fu Y, Davies MG. Urokinase requires NAD(P)H Oxidase to transactivate the Epidermal Growth Factor Receptor. Surgery 2012; 152(5):879-85 PMC3419340.

  Karmonik C, Partovi S, Loebe M, Schmack B, Ghodsizad A, Robbin MR, Noon GP, Kallenbach K, Karck M, Davies MG, Lumsden AB, Ruhparwar A. Influence of LVAD Cannula Outflow Tract Location on Hemodynamics in the Ascending Aorta: A Patient-Specific Computational Fluid Dynamics Approach. ASAIO J. 2012; 58(6):562-7.

  Duran CA, Naoum JJ, Smolock CJ, Bavare C, Patel MS, Anaya-Ayala JE, Lumsden AB, Davies MG. A Longitudinal View of Improved Management Strategies and Outcomes following Iatrogenic Iliac Artery Rupture During Endovascular AAA Repair. Ann Vasc Surg 2012; 27(1):1-7.

  Davies MG. Critical Limb Ischemia - Introduction. Methodist DeBakey Cardiovascular Journal 2012; 8(4):2.

  Davies MG. Critical Limb Ischemia - Epidemiology. Methodist DeBakey Cardiovascular Journal 2012; ; 8(4):10-14.

  Davies MG. Critical Limb Ischemia - Advanced Medical Therapy. Methodist DeBakey Cardiovascular Journal 2012; 8(4):3-9.

  Davies MG. Critical Limb Ischemia - Cell and Molecular Therapies for Limb Salvage. Methodist DeBakey Cardiovascular Journal 2012; 8(4):20-7.

  Davies MG. Critical Limb Ischemia - Reporting Quality and Outcomes. Methodist DeBakey Cardiovascular Journal 2012; ; 8(4):15-9.

  Duru EA, Fu Y, Davies MG. Role of S-1-P Receptors and human vascular smooth muscle cell migration in diabetes and metabolic syndrome. J Surg Res 2012 177(2): e75–e82. PMC3392410.

  Smolock CJ, Anaya-Ayala JE, Naoum JJ, Bismuth J, Peden EK, Lumsden AB, Davies MG Clinical efficacy of concomitant Tibial interventions associated with SFA interventions in critical limb ischemia. J Vasc Surg 2013; 57(1): 19-27.

  Nader Z, Anaya-Ayala JE, Ismail N, Davies MG, Peden EK. Prophylactic distal revascularization and interval ligation procedure during femoral vein transposition fistula creation in patients at high risk for ischemic complications. Ann Vasc Surg 2013; 27(3):353.

  Zou Y, Fu Y, Duru EA, Davies MG. Gαq G proteins modulate MMP-9 gelatinase during remodeling of the murine femoral artery. J Surg Res 2013;181(1):32-40 PMC3424329.

  Woo K, Eldrup-Jorgensen J, Hallett JJ, Davies MG, Beck A, Upchurch Jr GR, Weaver FA, Cronenwett JL. Regional Quality Groups in the SVS Vascular Quality Initiative. J Vasc Surg 2013; 57(3):884-90.

  Smolock CJ, Anaya-Ayala JE, Bismuth J, Naoum JJ, ElSayad HE, Hassoun H, Peden EK, Lumsden AB, Davies MG. Current Efficacy of Open and Endovascular Interventions for Advanced Superficial Femoral Artery Occlusive Disease. J Vasc Surg 2013;57(1):19-27.

  Saad WE, Wagner CC, Al-Osaimi A, Bliebel W, Lippert A, Davies MG, Sabri SS, Turba UC, Matsumoto AH, Angle JF, Caldwell S. The effect of balloon-occluded transvenous obliteration of gastric varices and gastrorenal shunts on the hepatic synthetic function: a comparison between child-pugh and model for end-stage liver disease scores. Vasc Endovascular Surg. 2013;47(4):281-7.

  Saad WE, Darwish WM, Davies MG, Kumer S, Anderson C, Waldman DL, Schmitt T, Matsumoto AH, Angle JF. Transjugular intrahepatic portosystemic shunts in liver transplant recipients: technical analysis and clinical outcome. AJR Am J Roentgenol. 2013;200(1):210-8.

  Saad WE, Nicholson D, Lippert A, Wagner CC, Turba CU, Sabri SS, Davies MG, Matsumoto AH, Angle JF Balloon-Occlusion Catheter Rupture During Balloon-Occluded Retrograde Transvenous Obliteration of Gastric Varices Utilizing Sodium Tetradecyl Sulfate: Incidence and Consequences. Vasc Endovascular Surg. 2012;46(8):664-70.

  Saad WEA, Lippert AJ, Davies MG, Arslan B, Kumer S, Waldman DL, Turba UC, Schmitt TM, Matsumoto AH, Angle JF. Prevalence, Presentation, and Endovascular Management of Hemodynamically or Clinically Significant Arterio-Portal Fistulae in Living- and Cadaveric-Donor Liver Transplant Recipients. Clinical Transpl 2012;26(4):532-8.

  Saad WEA, Dasgupta N, Lippert AJ, Turba UC, Davies MG, Kumer S, Gardenier JC, Sabri SS, Park A-W, Schmitt TM, Matsumoto AH, Angle JF. Extrahepatic Pseudoaneurysms and Ruptures of the Hepatic Artery in Liver Transplant Recipients: Endovascular Managment and a New Iatrogenic Etiology. CardioVasc Intervent Radiol 2013;36(1):118-27.

  Saad WE, Darwish WM, Davies MG, Kumer S, Anderson C, Waldman DL, Schmitt T, Matsumoto AH, Angle JF. Transjugular intrahepatic portosystemic shunts in liver transplant recipients: technical analysis and clinical outcome. AJR Am J Roentgenol 2013 Jan;200(1):210-8.

  Karmonik C, Partovi S, Davies MG, Bismuth J, Shah DJ, Bilecen D, Staub D, Noon GP, Loebe M, Bongartz G, Lumsden AB. Integration of the computational fluid dynamics technique with MRI in aortic dissections. Magn Reson Med. 2013 May;69(5):1438-42.

  Younes HK, Davies MG, Peden EK. End-stage renal disease and limb salvage. Methodist Debakey Cardiovasc J. 2013 Apr;9(2):108-11.

  Davies MG, Anaya-Ayala JE. Endovascular techniques in limb salvage: cutting, cryo, brachy, and drug-eluting balloons. Methodist Debakey Cardiovasc J. 2013 Apr;9(2):69-72.

  Ouriel K, Fowl RJ, Davies MG, Forbes TL, Gambhir RPS, Morales JP, Ricci MA, Society for Vascular Surgery: Reporting standards for adverse events after medical device use in the peripheral vascular system. J Vasc Surg 2013; 58(3):776-86.

  Patel MS, Hassoun HT, Davies MG, Lumsden AB. Single stage repair of a complex type B aortic dissection associated with a pressurized infrarenal abdominal aortic aneurysm. Ann Vasc Surg 2013; 27(8):1182.e9-e12.

  Saad WEA, Wagner C, Lippert A, Al-Ossaimi AM, Davies MG, Matsumoto AH, Angle JF, Caldwell S. Protective Value of Transjugular Intrahepatic Portosystemic Shunts (TIPS) Against Hydrothorax and/or Ascites After Balloon-occluded Retrograde Tranvenous Obliteration (BRTO) of Gastric Varices. Am J Gastroenterol 2013 108(10):1612-9.

  Bavare CS, Bismuth J, El-Sayed HF, Huynh TT, Peden EK, Davies MG, Lumsden AB and Naoum JJ. Volume Flow Measurements in Arteriovenous Dialysis Access in Patients with and without Steal Syndrome. Inter J Vasc Med 2013:1-4.

  Karmonik C, Müeller-Eschner M, Partovi S, Geisbüesch P, Ganten MK, Bismuth J, Davies MG, Böckler D, Loebe M, Lumsden AB, von Tengg-Kobligk H. Computational Fluid Dynamics Investigation of Chronic Aortic Dissection Hemodynamics Versus Normal Aorta. Vasc Endovascular Surg 2013; 47(8):625-31.

  Davies MG. Renal interventions during EVAR. Sem Vasc Surg 2013; 26:189–192.

  Saad WE, Bleibel W, Adenaw N, Wagner CE, Anderson C, Angle JF, Al-Osaimi AM, Davies MG, Caldwell S.Thrombocytopenia in Patients with Gastric Varices and the Effect of Balloon-occluded Retrograde Transvenous Obliteration on the Platelet Count. J Clin Imaging Sci 2014; 4:24.

  Ouriel K, Fowl RJ, Davies MG, Forbes TL, Gambhir RPS, Ricci MA, Society for Vascular Surgery. Disease-Specific Guidelines For Reporting Adverse Events For Peripheral Vascular Medical Devices. J Vasc Surg 2014;60(1):212-25.

  Naoum JJ, Chamoun MR, Patel MS, Street TK, Haydar M, Bismuth J, El-Sayed HF, Davies MG, Peden EK, Lumsden AB. Elevated heparin induced antibodies are more common in diabetic patients with vascular disease. Thrombosis 2014:649652.

  Fu Y, Duru EA, Davies MG. Effect of metabolic syndrome on the response to arterial injury. J Surg Res 2014; 191(1):33-41. PMC4134773.

  Ramlawi B, Al-Jabbari O, Blau LN, Davies, MG, Bruckner BA, Blackmon SH, Vinod RV, Benjamin R, Rodriguez L, Shapira OM, Reardon MJ. Autotransplantation for the resection of complex left heart tumors. Ann Thorac Surg 2014; 98(3):863-8.

  Naoum JJ, Bismuth J, El-Sayed HF, Davies MG, Peden EK, Lumsden AB. Open arterial revascularization of the critically ischemic foot using arterial homograft. J Med Liban 2014;62(3):125-9.

  Kalish J, Farber A, Homa K, M Trinidad M, Beck A, Wyers M, Davies MG, Chiriano J, Tracci M, Kraiss LW, Cronenwett JL. Factors Associated with Surgical Site Infection after Lower Extremity Bypass in the SVS Vascular Quality Initiative (VQI) – a National Perspective. J Vasc Surg 2014; 60(5):1238-46.
  Duru EA, Fu Y, Davies MG. Protease mediated human smooth muscle cell proliferation by Urokinase requires Epidermal Growth Factor Receptor transactivation by triple membrane signaling. J Surg Res 2014; 191(1):33-41. PMC4252843.

  Davies MG, Saad WE. Impact of elevated perioperative fasting blood glucose on carotid artery stenting outcomes. Ann Vasc Surg 2014; 28(8):1885-91.

  Patel MS, Street T, Davies MG, Peden EK, Naoum JJ. Evaluating and treating venous outflow stenoses is necessary for the successful open surgical treatment of arteriovenous fistula aneurysms. J Vasc Surg 2015; 61(2):444-8.

  Smolock CJ, ElSayed HF, Davies MG. Outcomes of femoro-popliteal interventions for critical ischemia in the hemodialysis-dependent patient. Ann Vasc Surg 2015; 29(2):237-43.

  Fischer UM, Davies MG, El-Sayed HF. Dissection of the left iliac artery during anterior lumbar interspace fusion – report of a case. Vascular 2015; 23(2):176-8.

  Younnes HK, ElSayed HF, Davies MG. Retrograde transpopliteal access is safe and effective - it should be added to the vascular surgeon's portfolio. Ann Vasc Surg 2015; 29(2):260-5.

  Duru EA, Fu Y, Davies MG. Role of Formic Receptors in soluble Urokinase Receptor induced human vascular smooth muscle migration. J Surg Res 2015; 195(2):396-405. PMC4417467.

  Anaya-Ayala JE, Loebe M, Davies MG. Endovascular Management of Early Lung Transplant-related Anastomotic Pulmonary Artery Stenosis. J Vasc Interv Radiol 2015; 26(6):878-882.

  Patel MS, Davies MG, Nasser GM, Naoum JJ. Open Repair and Venous Inflow Plication (ORVIP) of the Arteriovenous Fistula ((AVF) is effective in treating Vascular Steal Syndrome. Ann Vasc Surg 2015; 29(5):927-33.

  Lu T, Fischer UM, Marco RA, Naoum, JJ, Reardon MJ, Lumsden AB, Blackmon SH, Davies MG. En Bloc Resection of Pancoast Tumor with Adjuvant Aortic Endograft and Chemo-radiation: Case report and review of the literature. Methodist DeBakey Cardiovascular J 2015; 11(2):140-4.

  Davies MG, ElSayed HF. Outcomes of Isolated Tibial Endovascular Interventions in Patients on Hemodialysis with Tissue Loss. J Endovasc Ther 2015; 22(5):681-9.

  Anaya-Ayala JE, Davies MG, ElSayed HF, Peden EK, Naoum JJ. Experience with a Novel Hybrid Vascular Graft for Hemodialysis Access Creation in Patients with Disadvantaged Anatomy. J Endovasc Ther 2015; 22(5):778-85.

  Lu T, Anaya-Ayala JE, Reardon MJ, Peden EK, Davies MG, Right Brachial to Atrial Xenograft Conduit for Hemodialysis Access: A Case Report. Ann Vasc Surg 2015; 29(8):1662.e13-8.

  Davies MG, ElSayed HF. Objective Performance Goals following Endovascular Intervention for Critical Limb Ischemia. J Vasc Surg 2015; 62:1555-63.

  Davies MG, Hart JP, ElSayed HF. Efficacy Of Prophylactic Inferior Vena Caval Filters in Prevention of Pulmonary Embolism in the absence of Deep Venous Thrombosis. J Vasc Surg - Venous and Lym Dis 2016; 4 (1), 127-130.

  ElSayed HF, Kerensky R, Stecher M, Mohanty P. Davies MG. A Randomized Phase II Study of Xilonix, a Targeted Therapy Against Interleukin 1 alpha, for the Prevention of Superficial Femoral Artery Restenosis After Percutaneous Revascularization. J Vasc Surg 2016; 63 (1), 133-141.

  ElSayed HF Bennett ME, Loh TM, Davies MG, ElSayed HF. Retrograde Pedal access and endovascular revascularization: a safe and effective technique for high-risk patients with complex tibial vessel disease. Ann Vasc Surg 2016; 31:91-8.

  Davies MG, ElSayed HF. Current status of clot removal for acute pulmonary embolism. Ann Vasc Surg 2016; 31:211-20.

  Kibbe MR, Hirsch AT, Mendelsohn FO, Davies MG, Pham H, Saucedo J, Marston W, Pyun WB, Min SK, Peterson BG, Comerota A, Choi D, Ballard J, Bartow RA, Losordo DW, Sherman W, Driver V, Perin EC. Safety and efficacy of plasmid DNA expressing two isoforms of hepatocyte growth factor in patients with critical limb ischemia. Gene Ther 2016; 23(3):306-12.

  Davies MG, Anaya-Ayala JE, ElSayed HF. Equivalent outcomes with standard and heparin-bonded expanded polytetrafluoroethylene grafts used as conduits for hemodialysis access. J Vasc Surg 2016; 64:715-8.

  KimBJ, Valsangka NP, MurphyMP, Zimmers TA, Bell TM, Davies MG, Koniaris LG. Impact of Integrated Vascular Residencies on Academic Productivity within Vascular Surgery Divisions. Ann Vasc Surg 2017; 39:242-249.

  Davies MG, ElSayed HF. Outcomes of native superficial femoral artery chronic total occlusion recanalization after failed femoro-popliteal bypass. J Vasc Surg 2017; 65:728-35.

  Bavare CB, Street TK, Peden EK, Davies MG, Naoum JJ. Stent Grafts can Convert Unusable Upper Arm Arteriovenous Fistulas into a Functioning Hemodialysis Access. Frontiers Surgery 2017; Feb 27;4:13.

  Huang BY, Hicks TD, Haider GM, Pounds LL, Davies MG Vascular Surgery Training Program Websites: An Evaluation of the Availability, Accessibility, and Quality of Online Content for Residency and Fellowship Applicants. J Vasc Surg 2017; 66:1892-901.

  Lu T, Loh T, Smolock CJ, Birmbaum I, ElSayed HF, Davies MG. Ultrasound Accelerated Thrombolysis for the Management of Deep Venous Thrombosis. Vascular 2017; 25(5):525-532.

  Haidar GM, Hicks TD, ElSayed HF, Davies MG. Treatment options and outcomes for caval thrombectomy and resection for renal cell carcinoma. J Vasc Surg 2017; 5(3):430-436.

  Haidar GM, Hicks TD, Strosberg DS, ElSayed HF, Davies MG. "In situ" endografting in the treatment of arterial and graft infections. J Vasc Surg 2017; 65(6):1824-1829.

  Davies MG, Hicks TD, Haider GM, ElSayed HF. Outcomes of intervention for cephalic arch stenosis in brachiocephalic arterio-venous fistulas. J Vasc Surg 2017; 66:1504-10.

  Baer-Bositis HE, Hicks TD, Haider GM, Sideman MJ, Pounds LL, Davies MG. Outcomes of tibial endovascular intervention for rest pain in patients with ESRD on dialysis. Ann Vasc Surg 2018; 46:118-126.

  Strosberg DS, Oriowo B, Davies MG, ElSayed HF. The role of endovascular in-situ revascularization in the treatment of arterial and graft infections. Ann Vasc Surg 2017; 42:299-315.

  Chitragari G, Laux AT, Hicks TD, Davies MG, Haidar GM. Rare Presentation of a Syphilitic Aneurysm of the Infra-renal Aorta with Contained Rupture. Ann Vasc Surg 2017; (in press).

  Baer-Bositis HE, Hicks TD, Haider GM, Sideman MJ, Pounds LL, Davies MG. Outcomes of re-intervention after tibial endovascular intervention. J Vasc Surg 2017; (in press).

  Baer-Bositis HE, Hicks TD, Haider GM, Sideman MJ, Pounds LL, Davies MG. Outcomes of Tibial Endovascular Interventions in patients with Poor Pedal Runoff. J Vasc Surg 2017; 67:1788-96.

  Cheun TJ, Jayakumar L, Sheehan MK, Sideman MJ, Pounds LL, Davies MG. Outcomes of Upper Extremity Interventions for Chronic Critical Ischemia. J Vasc Surg. 2018; (in press).

  BOOK CHAPTERS:

  Davies MG, Brockbank KGM, Hagen P-O. Historical aspects of venous transplantation. In: Principles of autologous, allogeneic and cryopreserved venous transplantation. Ed. Brockbank KGM. RG Landes Company, Austin, TX, 1994.

  Davies MG, Brockbank KGM, Hagen P-O. Characteristics of the saphenous vein. In: Principles of autologous, allogeneic and cryopreserved venous transplantation. Ed. Brockbank KGM. RG Landes Company, Austin, TX, 1994.

  Davies MG, Brockbank KGM, Hagen P-O. Pathology of the saphenous vein. In: Principles of autologous, allogeneic and cryopreserved venous transplantation. Ed. Brockban, KGM. RG Landes Company, Austin, TX, 1994.

  Davies MG, Hagen P-O. The pathophysiologic consequences of autologous vein implantation. In: Principles of autologous, allogeneic and cryopreserved venous transplantation. Ed. Brockbank KGM. RG Landes Company, Austin, TX, 1994.

  Davies MG, Hagen P-O. Mechanisms of autologous vein graft failure and future possibilities for therapeutic control. In: Principles of autologous, allogeneic and cryopreserved venous transplantation. Ed. Brockbank KGM. RG Landes Company, Austin, TX, 1994.

  Davies MG, Hagen P-O. The effect of systemic vascular diseases on venous vasomotor function. In: Vascular Surgery Proceedings (Volume Two of Two). Eds. Wang Z-G, Becker, H-M, Mishima Y, Chang JB. International Academic Publishers, Beijing, China, 1994; 2:953-956.

  Davies MG, Hagen P-O. The local renin angiotensin system in vein grafts. In: Vascular Surgery Proceedings (Volume Two of Two). Eds. Wang Z-G, Becker, H-M, Mishima Y, Chang JB. International Academic Publishers, Beijing, China, 1994; 2:957-960.

  Brockbank KGM, Davies MG, Hagen P-O. Vein graft preparation for transplantation. In: Principles of autologous, allogeneic and cryopreserved venous transplantation. Ed. Brockbank KGM. RG Landes Company, Austin, TX, 1994.

  Davies MG, Hagen P-O. Physiology of Arterial System (Including Physiology of Nitric Oxide) In: Textbook of Surgery - The biological basis of modern surgery practice. Ed. Sabiston DC. WB Saunders, Philadelphia, PA, 15th edition. 1996.

  Davies MG, Hagen P-O. Physiology of Arterial System (Including Physiology of Nitric Oxide) In: The Companion to Textbook of Surgery. Ed. Sabiston DC. WB Saunders, Philadelphia, PA, 2nd edition. 1996.

  Davies MG, Sabiston DC. Acute Deep Vein Thrombosis and Pulmonary Embolism. In: Varicose veins, venous disorders and lymphatic problems in the lower limb. Ed. Tibbs DJ. Oxford University Medical Press, Oxford, UK. 1st edition. 1996.

  Davies MG, Hagen P-O. Intimal Hyperplasia. In: Textbook of Modern Vascular Surgery. Ed. Wang Z-G. International Academic Publishers, Beijing, China. 1st edition. 1997.

  Fulton GJ, Davies MG, Hagen P-O. Adhesion molecules as mechanoreceptors (Chapter 6). In: Adhesion Molecules in Health and Disease. Eds. Paul LC and Issekutz TB. Marcel Dekker Inc., NY. 1st edition. 1997:181-204.

  Davies MG, Hagen P-O. Atherosclerosis. In: Vascular Surgery Proceedings (Volume Three). Ed. Wang Z-G. International Academic Publishers, Beijing, China, 1998; 3:301-348.

  Davies MG, Huynh TTT, Hagen P-O. Pathophysiology of Access Failure. In: Hemodialysis Vascular Access: Practice and Problems. Ed. Schwab SJ, Conlon PJ, Nicholson M. Oxford University Medical Press, Oxford, UK. 1st edition. 1998.

  Davies MG, Huynh TTT, Hagen P-O. Endothelial Physiology. In: Ischaemia-Reperfusion Injury. Ed. Mathie R and Grace P. Blackwell Science, Oxford, UK. 1st edition. 1998.

  Davies MG, Huynh TTT, Hagen P-O. Vein grafts and systemic vascular disease. In: Vascular Surgery Proceedings (Volume Three). Ed. Wang Z-G. International Academic Publishers, Beijing, China, 1998; 3:399-407.

  Huynh TTT, Davies MG, Hagen P-O. Tissue Factor in the pathobiology of vein grafts. In: Vascular Surgery Proceedings (Volume Three). Ed. Wang Z-G. International Academic Publishers, Beijing, China, 1998; 3:385-388.

  Davies MG, Lee DE, Green RM. Current spectrum of Thrombolysis. In Endovascular Surgery. Ed. Moore W, Ahn S; WB Saunders Philadelphia PA. 3rd edition. 2001; 255-274.

  Gorti R, Lee DE, Davies MG. Venous and thromboembolic disease. In Unbound Surgery. Ed. Pappas T 1st edition Unbound Medicine Inc 2004 (http://www.unboundmedicine.com/surgery/) 

  Davies MG. Acute Embolic Disease. In Clinical Scenarios of Vascular Surgery. Ed. Upchurch G and Henke P. Lippincott Williams and Wilkins Philadelphia PA. 1st edition. 2004; 342-348.

  Davies MG. Acute Aortic Occlusive Disease in the Hostile Abdomen. In: Clinical Scenarios of Vascular Surgery. Ed. Upchurch G and Henke P. Lippincott Williams and Wilkins Philadelphia PA. 1st edition. 2004; 215-218.

  Davies MG. Intimal Hyperplasia: Basic Responses to Vascular Injury and Reconstruction. In: Vascular Surgery. Ed. Rutherford RB. Elsevier Science (USA) Philadelphia, PA. 6th edition. 2005.

  Davies MG. Intimal Hyperplasia: Basic Responses to Vascular Injury and Reconstruction. In: Review of Vascular Surgery: Companion to Vascular Surgery. Ed. Rutherford RB. Elsevier Science (USA) Philadelphia, PA. 2nd edition. 2005.

  Wolford HY, Davies MG. Endovascular Procedures for Lower-Extremity Vascular Disease. 6.23 Vascular System. In: ACS Surgery Principles & Practice Online. Ed. Souba WW, Fink MP, Jurkovich GJ, Kaiser LR, Pearce WH, Pemberton JH, Soper NJ. WebMD Inc and American College of Surgeons New York. 2005 (http://www.acssurgery/)

  Davies MG. Stem cells and response to vascular injury. Supplement to Intimal Hyperplasia: Basic Response to Arterial and Vein Graft Injury and Reconstruction. Vascular Surgery. Ed. Rutherford RB, Elsevier Science (USA) Philadelphia, PA. 6th edition. 2004 (supplement 2006).

  Saad WEA, Orloff MC, Davies MG, Waldman DL, Bozorgzadeh A. Post-Transplant Biliary and Vascular Surgical Anatomy. Editor: Razavi M & Semba C. Guest Editors: Saad WEA & Waldman DL. Liver Transplantation Interventions, Tech Vasc Interv Radiol 2007 10 (3): 172-190.

  Saad WEA, Davies MG, Darcy MD. Management of bleeding after percutaneous transhepatic cholangiography or transhepatic biliary drain placement. In: Biliary Interventions I. Editor: Razavi M & Semba C. Guest Editors: Saad WEA & & Darcy MD. Tech Vasc Interv Radiol 2008; 25 (3): I60-71.

  Hedegard W, Saad WEA, Davies MG. Management of vascular and non-vascular complications after renal transplantation. In: Renal Adrenal and Uretral Management –Part 2. Editor: Razavi M & Semba C. Guest Editors: Saad WEA. Tech Vasc Interv Radiol 2009; 12(4): 240-262.

  Davies MG. Intimal Hyperplasia: Basic Responses to Vascular Injury and Reconstruction. In: Vascular Surgery. Eds. Johnston KW Cronenwett, J. Elsevier Science (USA) Philadelphia, PA. 7th edition. 2010.

  Davies MG. Intimal Hyperplasia: Basic Responses to Vascular Injury and Reconstruction. In: Review of Vascular Surgery: Companion to Vascular Surgery. Ed. Johnston KW Cronenwett, J. Elsevier Science (USA) Philadelphia, PA. 3nd edition. 2010.

  Ginat DT, Davies MG, Saad WEA. Imaging in the Diabetic foot, In: High Risk Diabetic Foot: Treatment and Prevention. Eds. Lavery LK, Peters EJG, Bush RL. Informa Health Care USA Inc. 1st Edition 2009

  Charlton-Ouw KM, Davies MG, Lumsden AB. Balloon Angioplasty in Aorto-iliac Arterial Occlusive Disease. In Vascular Surgery. Ed. Moore WS; WB Saunders Philadelphia PA. 3rd edition. 2009;

  Charlton-Ouw KM, Davies MG, Lumsden AB. Stented Balloon Angioplasty in Aortoiliac Arterial Occlusive Disease. In Vascular Surgery. Ed. Moore WS; WB Saunders Philadelphia PA. 3rd edition. 2009;

  Bismuth J, Karmonik C, Shah D, Davies MG, Lumsden AB. New Dimensions in Diagnostic Imaging of the Aorta. In: Computational Surgery and Dual Training. Ed. Garbey M, Bass B. Springer Verlag New York, NY. 1st Edition, 2010.

  Vykoukal D, Davies MG. Changing Paradigms in the Management of Peripheral Vascular Disease. In: Computational Surgery and Dual Training. Ed. Garbey M, Bass B. Springer Verlag New York, NY. 1st Edition, 2010.

  Vykoukal D, Davies MG. Central venous Stenosis. In: Venous Disease – Contemporary Management. Ed. Lumsden AB, Davies MG. Cardiotext Inc., Minneapolis, MN. 1st Edition, 2010. 

  Vykoukal D, Davies MG. Iliofemoral Deep Venous Thrombosis. In: Venous Disease – Contemporary Management. Ed. Lumsden AB, Davies MG. Cardiotext Inc., Minneapolis, MN. 1st Edition, 2010.

  Vykoukal D, Davies MG. Pharmacological lysis. In: Venous Disease – Contemporary Management. Ed. Lumsden AB, Davies MG. Cardiotext Inc., Minneapolis, MN. 1st Edition, 2010.

  Vykoukal D, Davies MG. Deep Venous Thrombosis: Prevention. In: Venous Disease – Contemporary Management. Ed. Lumsden AB, Davies MG. Cardiotext Inc., Minneapolis, MN. 1st Edition, 2010.

  Garbey M, Davies MG. Some remarks on solution verification and model validation of hemodynamic simulation. In: Pumps and Pipes. Ed. Davies MG, Lumsden AB. Kakadarias I, Kleine WE. Springer Verlag New York, NY. 1st Edition, 2010.

  Vykoukal D, Davies MG. Intravascular Imaging. In: Pumps and Pipes. Ed. Davies MG, Lumsden AB. Kakadarias I, Kleine WE. Springer Verlag New York, NY. 1st Edition, 2010

  Davies MG, Tsekos V, Yeniaras E. Robot-assisted Procedures with MRI guidance. In: Pumps and Pipes. Ed. Davies MG, Lumsden AB. Kakadarias I, Kleine WE. Springer Verlag New York, NY. 1st Edition, 2010.

  Cao S, Hernanadez S, Luce B, Owens M, Williams M, Davies MG. Feasibility Study of Pumps and Pipes: Paving the Path from Oilfield to Operating Room. In: Pumps and Pipes. Ed. Davies MG, Lumsden AB. Kakadarias I, Kleine WE. Springer Verlag New York, NY. 1st Edition, 2010.

  Davies MG. Pipeline to Circulation: The Story of the Kimray–Greenfield Inferior Vena Caval Filter. In: Pumps and Pipes. Ed. Davies MG, Lumsden AB. Kakadarias I, Kleine WE. Springer Verlag New York, NY. 1st Edition, 2010.

  Anaya Ayala JE, Davies MG, Peden EK, Lumsden AB. Management of Perforator Vein Incompetence. In: Haimovici’s Vascular Surgery. Ed. Ascher E. Wiley-Blackwell Medicine, 6th Edition, 2011.

  Anaya Ayala JE, Farley A, Davies MG, Lumsden AB. Magnetic Resonance Angiography In: Haimovici’s Vascular Surgery. Ed. Ascher E. Wiley-Blackwell Medicine. 6th Edition, 2011.

  Anaya Ayala JE, Saad W, Davies MG, Lumsden AB. Endovascular Treatment of Splenic and Hepatic Artery Aneurysms. In: Atlas Vascular Surgery and Endovascular Therapy. Ed. Chaikof EL, Cambria R. Elsevier, 2011.

  Davies MG. Surgical and endovascular management of lower extremity claudication. In: UpToDate, Ed. Collins K, Wolters Kluwer Health - UpToDate, Waltham, MA, 2011.

  Davies MG. Management of lower extremity critical ischemia. In: UpToDate, Ed. Collins K, Wolters Kluwer Health - UpToDate, Waltham, MA, 2011.

  Davies MG. Clinical manifestations and clinical diagnosis of lower extremity peripheral artery disease In: UpToDate, Ed. Collins K, Wolters Kluwer Health - UpToDate, Waltham, MA, 2011.

  Vykoukal D and Davies MG. Metabolic Syndrome and Vascular Outcomes. In: Vascular Surgery, Ed. Eskandari M, Morasch M, Pearce WH and Yao JST. Peoples Medical Publishing House-USA (PMPH-USA), Shelton CT, 2011. 243-254.

  Anaya Ayala JE, Davies MG, Reardon MJ. Cardiac surgery in the End Stage Renal Disease Population: General considerations, risk factors and Clinical Outcomes. In: Issues in Dialysis. Ed. Fadem SZ. Nova Science Publishers, Inc. Hauppauge, NY. 1st Edition, 2011.

  Anaya-Ayala JE, Davies MG, Bismuth JB, Lumsden AB The Role of Simulators in Endovascular Training. In Vascular and Endovascular Consensus Update. Ed. Greenhalgh R. BIBA Medical Ltd, London UK. 1st Edition, 2011.

  Ramlawi B, Reardon MJ, Davies MG, Lumsden AB. Contemporary Management of aortic Arch Aneurysms. In: Vascular Surgery, Ed. Eskandari M, Morasch M, Pearce WH and Yao JST. Peoples Medical Publishing House-USA (PMPH-USA), Shelton CT, 2012.

  Vykoukal D, Davies MG. Cardiovascular imaging, navigation and intervention - hybrid imaging and therapeutics. In: Computational Surgery and Dual Training II. Ed. Garbey M, Bass B. Springer Verlag New York, NY. 2nd Edition, 2012.

  Karmonik C, Bismuth J, Shah DJ, Davies MG, Lumsden AB. Assessment of Hemodynamics in DeBakey Type III Aortic Dissections For Planning Surgical Interventions and to Understand Post-Treatment Changes. In: Computational Surgery and Dual Training II. Ed. Garbey M, Bass B. Springer Verlag New York, NY. 2nd Edition, 2012.

  Vykoukal D, Anaya-Ayala JE, Lumsden AB, Davies MG. Contrast-Enhanced Ultrasound. In: Noninvasive Vascular Diagnosis: A Practical Guide to Therapy. Ed. AbuRahma AF, Bergen JJ. Springer Verlag New York, NY. 4th Edition, 2012.

  Anaya Ayala JE, Vykoukal D, Lumsden AB, Davies MG. Percutaneous Interventions for Fibrodysplastic Renovascular Hypertension. In: Current Therapy in Vascular and Endovascular Surgery. Eds. Stanley JC, Wakefield TW, Veith FJ. Elsevier Science (USA) Philadelphia, PA. 5th Edition, 2012.

  Smolock CJ, Vykoukal D, Lumsden AB, Davies MG. Percutaneous Interventions for Fibrodysplastic Renovascular Hypertension. In: Current Therapy in Vascular and Endovascular Surgery. Eds. Stanley JC, Wakefield TW, Veith FJ. Elsevier Science (USA) Philadelphia, PA. 5th Edition, 2012.

  Patel MS, Davies MG. Renal Artery Embolism – A Cause of Renal Failure. In: Current Therapy in Vascular and Endovascular Surgery. Eds. Stanley JC, Wakefield TW, Veith FJ. Elsevier Science (USA) Philadelphia, PA. 5th Edition, 2012.

  Bavare C, Davies MG Thrombotic Complications of Arterio-venous access. In: Current Therapy in Vascular and Endovascular Surgery. Eds. Stanley JC, Wakefield TW, Veith FJ. Elsevier Science (USA) Philadelphia, PA. 5th Edition, 2012.

  Vykoukal D, Anaya-Ayala JE, Davies MG. Treatment Of Renal Artery Stenosis and Fibromuscular Dysplasia. In: New Techniques in Surgery - Vascular Surgery. Eds. Hoballah J, Lumsden AB. Springer Verlag New York, NY. 1st Edition, 2012.

  Vykoukal D, Davies MG. Changing basic science considerations with endovascular therapy In: Handbook of Endovascular Interventions. Ed. Kumar A, Oriel K. Ouriel K, Kumar A. Humana Press, Totowa, NJ. 2012.

  Anaya-Ayala JE, Bismuth J, Davies MG, Lumsden AB. Simulators in Endovascular Treatment. In: Handbook of Endovascular Interventions. Ed. Kumar A, Oriel K. Ouriel K, Kumar A. Humana Press, Totowa, NJ. 1st Edition, 2012.

  Davies MG. Endovascular Procedures for Lower-Extremity Vascular Disease. 6.23 Vascular System. In: ACS Surgery Principles & Practice Online. Ed. Souba WW, Fink MP, Jurkovich GJ, Kaiser LR, Pearce WH, Pemberton JH, Soper NJ. WebMD Inc and American College of Surgeons New York. 2012 (http://www.acssurgery/)

  Loebe M, Davies MG. Quality Control in Cardiac Surgery in the United States. In: Cardiac Surgery: Operations on the Heart and Intrathoracic Vessels. Eds. Ziemer G, Haverich A. Springer Verlag New York, NY. 1st Edition, 2013.

  Davies MG. Surgical And Endovascular Complications. In Essentials of Vascular Surgery for the General Surgeon. Eds. Gahtan V, Contanza M. Springer Verlag New York, NY. 1st Edition, 2014.

  Davies MG. Same Day Discharge after CEA. In: Clinical Scenarios of Vascular Surgery. Ed. Upchurch G and Henke P. Lippincott Williams and Wilkins Philadelphia PA. 2nd edition. 2014.

  Davies MG. Acute Aortic Occlusive Disease in the Hostile Abdomen. In: Clinical Scenarios of Vascular Surgery. Ed. Upchurch G and Henke P. Lippincott Williams and Wilkins Philadelphia PA. 2nd edition. 2014.

  Davies MG. Intimal Hyperplasia: Basic Responses to Vascular Injury and Reconstruction. In: Vascular Surgery. Eds. Sidway A, Perler B. Elsevier Science (USA) Philadelphia, PA. 9th edition. 2018.

  Davies MG. Intimal Hyperplasia: Basic Responses to Vascular Injury and Reconstruction. In: Review of Vascular Surgery: Companion to Vascular Surgery. Ed. Sidway A, Perler B. Elsevier Science (USA) Philadelphia, PA. 5th edition. 2018.

  Berger JS, Davies MG. Overview of lower extremity peripheral artery disease In: UpToDate, Ed. Collins KA, Wolters Kluwer Health - UpToDate, Waltham, MA, 2018.

  Davies MG, Mohler E. Management of claudication. In: UpToDate, Ed. Collins KA, Wolters Kluwer Health - UpToDate, Waltham, MA, 2018.

  Baer-Bositis HE, Haider GM, Hicks TD, Davies MG. Endovascular Treatment of Vascular Trauma In Endovascular Interventions. Eds. Wiley JM, Krishnan P, Faries P. DelConde I, Dangas G. Wiley Blackwell 1st Edition 2017.

  Davies MG. Standard versus Heparin-Bonded Grafts for Dialysis Access. . In: Current Vascular Surgery- 2017, Eds. Eskandari M, Pearce WH and Yao JST. Peoples Medical Publishing House-USA (PMPH-USA), Shelton CT, 2018.

  Jayakumar L, Davies MG. Endovascular Procedures for Lower Extremity Arterial Disease – The Basics. In: Scientific American Vascular and Endovascular Surgery (SAVES). Ed. Valentine J. Scientific American Surgery Decker Intellectual Properties, Toronto, ON. Canada. 1st Edition 2018.

  Jayakumar L, Davies MG. Endovascular Procedures for Lower Extremity Arterial Disease – The Specifics. In: Scientific American Vascular and Endovascular Surgery (SAVES). Ed. Valentine J. Scientific American Surgery Decker Intellectual Properties, Toronto, ON. Canada. 1st Edition 2018.

  Cheun, TJ, Jayakumar L, Davies MG. General Complications of EVAR. In: Complications in Endovascular Surgery. Eds. Harris LM, Dryjski M. Elsevier Science (USA) Philadelphia, PA. 1st edition. 2018.

  Berger JS, Davies MG. Patient education: Peripheral artery disease and claudication (Beyond the Basics). In: UpToDate, Ed. Collins KA, Wolters Kluwer Health - UpToDate, Waltham, MA, 2018.

  Davies MG. Standard versus Heparin-Bonded Grafts for Dialysis Access. . In: Upper Extremity and Vascular Access, Eds. Eskandari M and Tomita TM. Peoples Medical Publishing House-USA (PMPH-USA), Shelton CT, 2019.

  EDITED BOOKS:

  Davies MG, Lumsden AB: Contemporary Endovascular Management - Chronic Venous Insufficiency. Cardiotext Inc., Minneapolis, MN 2010.

  Davies MG, Klein WE, Lumsden AB Kakadiaris I: Pumps and Pipes. Springer Verlag New York, NY. 2010.

  Davies MG, Lumsden AB: Contemporary Endovascular Management - Venous Thromboembolic disease. Cardiotext Inc., Minneapolis, MN 2011.

  PUBLICATIONS FROM COMPLETED MULTI-CENTER TRIALS AND COMMITTEES:

  Goyen M, Edelman M, Perreault P, O'Riordan E, Bertoni H, Taylor J, Siragusa D, Sharafuddin M, Mohler ER 3rd, Breger R, Yucel EK, Shamsi K, Weisskoff RM for the EPIX investigators (Barr R, Morris C, Davies MG, Poon M, Allen W.Reid AW, Barkhausen J, Becker L,O’Moore P). MR angiography of aortoiliac occlusive disease: a phase III study of the safety and effectiveness of the blood-pool contrast agent MS-325. Radiology 2005 Sep;236(3):825-33.

  Lipsky BA, Armstrong DG, Citron DM, Tice AD, Morgenstern DE, Abramson MA for SIDESTEP investigators (Adler JC, Altmanshofer BJ, Baird I, Barbaro D, Bellos NC, Brill L, Brown MD, Chagares W, Charles R, Cohen M, Cunningham M, Davies MG, DeHaven JW, DeJesus E,DeMaio J, Drossner  B, Dubay G, Ellison WT, Feleke G, Fogelfeld L, Forman P, Fox IM, Friedman B, Galperin R, Gilbert D, Gordon I, Hackenberg T, Halperin GJ, Hamill RJ, Hassman D, Horwitz L, Hunt JP, Jacocks MA, Johnson JB, Jones G, Jones L, Kales L, Karchmer AW, Kay DB, Kelley M, Khaladj M, Kipnes M, Kipp  LJ, Klein S, Liljenquist J, Lipsky BA, Lucasti C, Luterman A, Minei JP, Mondy JS, Moore E, Morales-Ramirez JO, Morgan J, Mulliken R, Nixon B, Norwood P, Offutt A,Osiyemi O, Page JC,Peskind RL, Pollak R,Qazi K, Ramanujan RA, Ramirez-Ronda CH, Raymond GA, Ribotsky B, Robertson J,Carrasquillo LR, Romano JM, Rothenberg G, Rushton TC, Salzer PA, Satterfield KSchroeder D, Sheehan P, Sheehan KK, Lambuth Smith D, Miguel Sosa-Padilla M, Steven Spinner S, Scott Stienecker S, Stone J, Suh B, Tice A,Vogler TA, Warren J, Wilkin M, Zelen CM,). Ertapenem versus piperacillin/tazobactam for diabetic foot infections (SIDESTEP): prospective, randomised, controlled, double-blinded, multicentre trial. Lancet. 2005 Nov 12;366(9498):1695-703.

  Brass EP, Anthony R, Dormandy J, Hiatt WR, Jiao J, Nakanishi A, McNamara T, Nehler M for the CIRCULASE investigators (Garofalo J Dennis Ruff D, McShannic J, Thomas McNamara T, Gregory L. Moneta GL, Snyder j, Rapp J, Crouse L, Berman S, Beajow M, Sheehan P, Schell WW, Fried D, Albery R, McLafferty R, Larimer R, Yonehiro L, Sawchuk AP, Patel S Rivera R, Boutros J, Anderson C, Simeon SB, Abou-Zamzam A, Johnson A, Kline AL, Rubin J Shanley C, Dormandy J, McCollum P, Bradbury A, Shearman C, Belch J, Mann, Jr WK, Davies MG, Martinez JM, Lamont P, Walker W, Gough M). Parenteral therapy with lipo-ecraprost, a lipid-based formulation of a PGE1 analog, does not alter six-month outcomes in patients with critical leg ischemia. J Vasc Surg. 2006 43:752-9.

  Conte MS, Bandyk DF, Clowes AW, Moneta GL, Seely L, Lorenz TJ, Namini H, Hamdan AD, Roddy SP, Belkin M, Berceli SA, DeMasi RJ, Samson RH, Berman SS, PREVENT III Investigators (Cossman D, H’Doubler W, McNeil J, Eidt J, Samson R, Cabellon S, DeMasi R, Pfeiffer R, Hye R, Mozersky D, Teodorescu V, Nowygrod R, Shanley C, Davies MG, Hill A, Bogey W, Tzeng E, Han D, Harris K, Powell R, Martinez J, Dalsing M, Guzman R, Lumsden A, Chaikof E, Gagne P, Dalman R, Edwards, W Jr, Geary R, Petrasek P, BrothersT, Eskandari M, Gupta S, H’Doubler P, Blebea J, Choi E, Kohler T, Marcaccio E, Veith F. Dyke C, Mills J, MD Rubin B, MD Sarfati M, Williams CM, Ascher E, Baxter T, Cambria R, Comerota A, Hsiang Y, Sarac T, Glickman M, Nackman G, Castronuovo J, Estes J, Silva M, Deitch J, Eldrup-Jorgensen J, Freeman M, Pappas P, Rehring T, Spelay J, Desai T, Jordan W, Noel A, Drezner D, Golden M, Lilly M, Kent C). Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. J Vasc Surg. 2006 Apr;43(4):742-751.

  Nguyen LL, Moneta GL, Conte MS, Bandyk DF, Clowes AW, Seely BL; PREVENT III Investigators (Cossman D, H’Doubler W, McNeil J, Eidt J, Samson R, Cabellon S, DeMasi R, Pfeiffer R, Hye R, Mozersky D, Teodorescu V, Nowygrod R, Shanley C, Davies MG, Hill A, Bogey W, Tzeng E, Han D, Harris K, Powell R, Martinez J, Dalsing M, Guzman R, Lumsden A, Chaikof E, Gagne P, Dalman R, Edwards, W Jr, Geary R, Petrasek P, BrothersT, Eskandari M, Gupta S, H’Doubler P, Blebea J, Choi E, Kohler T, Marcaccio E, Veith F. Dyke C, Mills J, MD Rubin B, MD Sarfati M, Williams CM, Ascher E, Baxter T, Cambria R, Comerota A, Hsiang Y, Sarac T, Glickman M, Nackman G, Castronuovo J, Estes J, Silva M, Deitch J, Eldrup-Jorgensen J, Freeman M, Pappas P, Rehring T, Spelay J, Desai T, Jordan W, Noel A, Drezner D, Golden M, Lilly M, Kent C). Prospective multicenter study of quality of life before and after lower extremity vein bypass in 1404 patients with critical limb ischemia. J Vasc Surg. 2006; 44(5):977-83; discussion 983-4.

  Nehler MR, Brass EP, Anthony R, Dormandy J, Jiao J, McNamara TO, Hiatt WR and the CIRCULASE investigators (Garofalo J Dennis Ruff D, McShannic J, Thomas McNamara T, Gregory L. Moneta GL, Snyder j, Rapp J, Crouse L, Berman S, Beajow M, Sheehan P, Schell WW, Fried D, Albery R, McLafferty R, Larimer R, Yonehiro L, Sawchuk AP, Patel S Rivera R, Boutros J, Anderson C, Simeon SB, Abou-Zamzam A, Johnson A, Kline AL, Rubin J Shanley C, Dormandy J, McCollum P, Bradbury A, Shearman C, Belch J, Mann, Jr WK, Davies MG, Martinez JM, Lamont P, Walker W, Gough M). Adjunctive parenteral therapy with lipo-ecraprost, a prostaglandin E1 analog, in patients with critical limb ischemia undergoing distal revascularization does not improve 6-month outcomes. J Vasc Surg. 2007; 45: 953-961.

  Powell RJ, Simons M, Mendelsohn FO, Daniel G, Henry TD, Koga M, Morishita R, Annex BH and HGF-STAT investigators. Results of a double-blind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia. Circulation. 2008;118(1):58-65.

  Demetriades D, for American Association for the Surgery of Trauma Thoracic Aortic Injury Study Group. Operative repair or endovascular stent graft in blunt traumatic thoracic aortic injuries: results of an American Association for the Surgery of Trauma Multicenter Study. J Trauma. 2008; 64(3):561-71.

  Demetriades D, for American Association for the Surgery of Trauma Thoracic Aortic Injury Study Group Diagnosis and treatment of blunt thoracic aortic injuries: changing perspectives. J Trauma. 2008; 64(6):1415-9.

  Powell RJ, Goodney P, Mendelsohn FO, Moen EK, Annex BH; HGF Trial Investigators.Safety and efficacy of patient specific intramuscular injection of HGF plasmid gene therapy on limb perfusion and wound healing in patients with ischemic lower extremity ulceration: results of the HGF-0205 trial. J Vasc Surg. 2010 Dec;52(6):1525-30.

  Powell RJ, Simons M, Mendelsohn FO, Daniel G, Henry TD, Koga M, Morishita R, Annex BH; HGF Trial Investigators, Results of a double-blind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia. Circulation. 2008 Jul 1;118(1):58-65.

  Moriarty JP, Murad MH, Shah ND, Prasad C, Montori VM, Erwin PJ, Forbes TL, Meissner MH, Stoner MC; Society for Vascular Surgery Committee on Comparative Effectiveness. A systematic review of lower extremity arterial revascularization economic analyses. J Vasc Surg 2011 Oct;54(4):1131- 1144.e1.

  Creager MA, Olin JW, Belch JJ, Moneta GL, Henry TD, Rajagopalan S, Annex BH, Hiatt WR. Effect of hypoxiainducible factor-1alpha gene therapy on walking performance in patients with intermittent claudication. Circulation. 2011 Oct 18;124(16):1765-73.

  OTHER:

  Davies MG, Hagen P-O. Book Review: Endothelial Regulation of Vascular Tone (Eds. Ryan US, Rubanyi GM) Marcel Dekker Inc., NY. 1992.  Ann Surg 1993; 217:203-204.

  Davies MG. Book Review: G-protein coupled receptors (Eds: Haga T, Bernstein G) CRC Press, Boca Raton, 2000. J Vasc Surg 2001:1138

  Davies MG.  Online CME module for Medical Simulation Corporation. Renal Stent Simulation Module 2001

  Davies MG. G-proteins and Intimal Hyperplasia. Web publication, In Basic Science on VascularWeb.org; Ed. Kent, KC. 2003

  Surowiec SM, Davies MG. Endoluminal therapy for Renal Artery Ostial Stenosis. Images in Vascular Disease on the VascularWeb 2004.

   http://www.vascularweb.org/_CONTRIBUTION_PAGES/Clinical_Information/Images_Cases/Renal_stenosis_Davies.html 

  Surowiec SM, Davies MG. Cryoplasty for superficial femoral artery occlusion. Images in Vascular Disease on the VascularWeb 2004.

  http://www.vascularweb.org/_CONTRIBUTION_PAGES/Clinical_Information/Images_Cases/Cryoplasty_superficial_femoral_artery_occlusion_Davies.html

  Galaria II, Davies MG. Embolization of an internal iliac artery aneurysm. Images in Vascular Disease on the VascularWeb 2004.

  http://www.vascularweb.org/_CONTRIBUTION_PAGES/Clinical_Information/Images_Cases/Embolization_Of_An_I nternal_Iliac_Artery_Aneurysm_Davies.html 

  Bakken AM, Davies MG.  Combined Mechanical and Pharmacological Thrombolysis for Iliofemoral DVT presenting as Phlegmasia Cerulea Dolens. Images in Vascular Disease on the VascularWeb 2005.

  http://www.vascularweb.org/_CONTRIBUTION_PAGES/Clinical_Information/Images_Cases/Combined_Mechanical_and_Pharmac-9_27_2005.html 

  Wolford HY, Davies MG. Stenting for carotid restenosis after carotid endarterectomy and carotid stenting. Images in Vascular Disease on the VascularWeb 2005.

  http://www.vascularweb.org/_CONTRIBUTION_PAGES/Clinical_Information/Images_Cases/Carotid_stenting_for_c arotid_re-1_9_2004.html 

  Davies MG, Suroweic SM. Reply to a letter regarding “Percutaneous angioplasty and stenting of the superficial femoral artery” J Vasc Surg 2005; 42:825.

  Sivamurthy N, Davies MG. Online CME module on “ Endovascular versus open mesenteric revascularization: immediate benefits do not equate with short term functional outcomes”. J Am Coll Surg 2006.

  Davies MG. Commentary on “Metabolic syndrome in peripheral arterial disease. Relationship with severity of peripheral circulatory insufficiency, inflammatory status and cardiovascular comorbidity” J Vasc Surg 2006;44(1):107.

  Bakken AM, Waldman DL, Davies MG. Endoluminal therapy for Traumatic Aortic Transection. Images in Vascular Disease on the VascularWeb 2006.

  http://www.vascularweb.org/_CONTRIBUTION_PAGES/Clinical_Information/Images_Cases/Endoluminal_therapy_for_Traumat-7_27_2006.html

  Bakken AM, Davies MG. Online CME module on “Impact of diabetes on the longterm outcomes of superficial femoral artery endoluminal interventions”. J Vasc Surg 2007.

  Bakken AM, Davies MG. Reply to a letter regarding "Impact of Diabetes Mellitus on Outcomes of Superficial Femoral Artery Endoluminal Interventions". J Vasc Surg 2008; 48(3):774-775.

  Lumsden AB, Davies MG. Commentary on “Current Indications for Carotid Angioplasty and Stenting” Perspect Vasc Surg Endovasc Ther. 2008 Sep;20(3):245-6.

  Davies MG. Online CME module on “Factors Impacting The Long Term Outcomes Of Percutaneous Therapy For Renal Artery Fibromuscular Dysplasia”. J Vasc Surg 2008.

  Davies MG. Online CME module on. “Endovascular Revascularization Of Renal Artery Stenosis In The Solitary Functioning Kidney”. J Vasc Surg 2009.

  Protack CD, Davies MG. Online CME module on “Metabolic Syndrome: a predictor of adverse events after Carotid Revascularization”. J Vasc Surg 2009.

  Vykoukal D, Davies MG. G-protein signaling (revised 2010). Web publication, In Basic Science on VascularWeb.org

  Peden EK, Davies MG, Anaya-Ayala JE. Reply to comment on "Unrecognized basilic vein variation leading to complication during basilic vein transposition arteriovenous fistula creation: Case report and implications for access planning".  Eur J Vasc Endovasc Surg 2010 40(2):283.

  Broadbent K, Hodge M, Votour C, Garami Z, Davies MG. CME module on “Duplex Assessment of carotid body tumor”. Ultrasound Today 2009.

  Hodge M, Broadbent K, Davies MG. CME module on “Fibromuscular Dysplasia”. Ultrasound Today 2011.

  Smolock CJ, Davies MG. SCORE Module: Embolectomy / Thrombectomy Artery; Category: Vascular – Arterial Disease   Type: Operation/Procedure.  APDS SCORE Curriculum 2010; Module number 300047.

  Davies MG. Renal Mesenteric Section Module: Vascular Education and Self Assessment Program-2 (VESAP-2), 2011.

  Davies MG. Discussion on Ghanami RJ, Rana H, Craven TE, Hoyle J, Edwards MS, Hansen KJ. Discussion: Diastolic function predicts survival after renal revascularization J Vasc Surg 2011; 54:1720- 6.

  Davies MG. Commentary: Three-Year Outcomes of the RESILIENT Trial: Are They Enough to Support a Primary Stenting Policy?  J Endovasc Ther. 2012 Feb;19(1):10-1.

  Davies MG. Commentary: Does 9 Months signal sustained results in the Claudicant? J Endovasc Ther 2013; 20(1): 104-5.

  Davies MG. Commentary: Newer Generation Stent Delivers Good 1-Year Functional Outcome in Patients With SFA Disease.  J Endovasc Ther. 2014; 21(4): 472-473.

  Davies MG. (2014, July). Hypercoaguable Syndromes. Retrieved from http://www.surgicalcore.org/

  Patel MS, Street T, Davies MG, Peden EK, Naoum JJ. Online CME module on “Evaluating and treating venous outflow stenoses is necessary for the successful open surgical treatment of arteriovenous fistula aneurysms”. J Vasc Surg 2015.

  Davies MG. New insights on the Role of SERCA during Vessel Remodeling in Metabolic Syndrome. Commentary: Metabolic syndrome abolishes glucagon-like peptide-1 receptor agonist stimulation of SERCA in coronary smooth muscle.   Diabetes 2015; 64(9):3066-8.

  Davies MG. Commentary: Co-administration of adipose-derived stem cells and control-released basic fibroblast growth factor facilitates angiogenesis in a murine ischemic hind limb model. J Vasc Surg 2016; 64(6):1834.

  Davies MG and the THA Leadership Fellows Class 2016. A clear path to improving behavioral Health: White Paper. Texas Hospital Association Jan 2017.

  Davies MG. Commentary: Osteoclastogenic Differentiation of Macrophages in the Abdominal Aorta of Ang II-Infused apoE-KO Mice. J Vasc Surg 2018; in press.

  Cheun T, Davies MG. SCORE Module: Embolectomy / Thrombectomy Artery; Category: Vascular – Arterial Disease Type: Operation/Procedure.  APDS SCORE Curriculum 2017; Module number.

  Davies MG. Commentary: Is Prophylactic Paving of Highly Calcified Femoropopliteal Occlusions All It’s Cracked Up to Be?   J Endovasc Ther 2018; 25(3):343-344.

  ABSTRACTS:

  Davies MG, Chamber PL, Rowan MJ. Stimulation of central synaptic transmission in the cockroach by methyl glyoxal. Ir J Med Sci 1985; 154:329.

  Davies MG, Rowan MJ, MacMathuna P et al. Evoked responses in the detection of subclinical hepatic encephalopathy. Ir J Med Sci 1988; 157:367.

  Davies MG, Rowan MJ, MacMathuna P et al. The use of the P300 event related potential in the assessment of early hepatic encephalopathy. Br J Clin Pharmacol 1988; 26:647-648.

  Davies MG, McCollum PT, Kent P et al. Intravenous pentoxyifylline in the treatment of rest pain - a preliminary report. Ir J Med Sci 1988; 157:364.

  Stanley ST, Davies MG, McCollum PT et al. The dependence of toe pressure measurements on ambient temperature. Ir J Med Sci 1988; 157:367.

  Davies MG, McCollum PT, Kent P et al. Intravenous pentoxyifylline increases tissue oxygenation in the treatment of established ischaemic rest pain. Br J Clin Pharmacol 1988; 26:650.

  Davies MG, Rowan MJ, MacMathuna P et al. Evoked responses in early hepatic encephalopathy. Ir J Med Sci 1989; 157:162.

  Davies MG, Gaine SP, Thakore J et al. The facet joints: a comparison of arthographic and pathological findings. Ir J Med Sci 1989; 158:135.

  Davies MG, Rowan MJ. Methyl glyoxal and adrenergic transmission. Ir J Med Sci 1989; 158:131.

  O’Marcaigh A, Gaine SP, Davies MG et al. Benign oesophageal strictures and rheumatoid arthritis. Ir J Med Sci 1989; 158:135.

  Davies MG, Lavelle J, Connolly JA et al. Analysis of a general surgical service - statistics under the microscope. Ir J Med Sci 1991; 160:226-227.

  Davies MG, Rowan MJ, MacMathuna P et al. Electroencephalographic event related potentials in the evaluation of early hepatic encephalopathy. Ir J Med Sci 1991; 160:75-76.

  Massey MF, Davies MG, Klyachkin ML et al. Modulation of bradykinin receptor expression in experimental vein grafts. FASEB J 1992; 6:A1042.

  Schwartz LB, Massey MF, Davies MG et al. Effect of in vitro pressurization on human saphenous vein vasoreactivity. FASEB J 1992; 6:A1041.

  O’Broin E, Davies MG, McGinley J et al. How good is traditional cholecystectomy? Ir J Med Sci 1992; 161:523.

  Kim JH, Klyachkin ML, Davies MG et al. Experimental hypercholesterolemia in rabbits induces cavernosal atherosclerosis. J Urol 1993; 149:246A.

  Svendsen E, Davies MG, Klyachkin ML et al. A new perspective on endothelial cell injury in vein grafts. FASEB J 1993; 7:A719.

  O’Farrell DA, Chen LE, Davies MG et al. Functional assessment of ischemia/reperfusion injury and protection in skeletal muscle. FASEB J 1993; 7:A806.

  Davies MG, Kim JH, Hagen P-O. Effect of hyperglycemia on venous vasomotor function. FASEB J 1993; 7:A321.

  Davies MG, Klyachkin ML, Massey MF, Svendsen E, Hagen P-O. Bradykinin receptor modulation in vein grafts. J Invest Surg 1993; 6:353.

  Davies MG, Klyachkin ML, Kim JH, Svendsen E, Hagen P-O. Prolonged hypercholesterolemia induces alterations in both endothelial and smooth muscle cell vasomotor function of veins without detectable morphological changes. J Invest Surg 1993; 6:353.

  Svendsen E, Davies MG, Klyachkin ML et al. The kinetics of PMNs in vein grafts. Pathol Res Pract 1993; 189:822.

  Davies MG, Kim YC, Kim JH, Hagen P-O, Carson CC. Nitric oxide and prostanoids modulate vasoactive intestinal polypeptide (VIP)-mediated relaxation in the rabbit corpus cavernosum. J Urol 1994; 151: 430A.

  Barry M, Davies MG, Connolly JA et al. Intensive care in an Irish District General Hospital - a three year review. Ir J Med Sci 1994; 163:73.

  Barry M, Davies MG, West M et al. Acute gastric surgery in a District Surgical Unit. Ir J Med Sci 1994; 163: 70.

  Kim JH, Davies MG, Svendsen E et al. L-arginine restores neural and endothelium-dependent /independent cavernosal relaxation in hypercholesterolemic rabbits. J Urol 1994; 151: 493A.

  Davies MG, Fulton GJ, Hagen P-O. The function of G-proteins and alpha adrenergic receptors in retrieved human vein grafts. J Am Coll Cardiol 1995; 75:413A.

  Davies MG, Fulton GJ, Hagen P-O. The effect of peri-operative storage solutions on the long term vein graft function and morphology. J Am Coll Cardiol 1995; 75:323A.

  Davies MG, Fulton GJ, Ramkumar V, Hagen P-O. Alterations in endothelial cell adenosine receptors mediate endothelium dependent vasoconstriction in experimental vein grafts. J Am Coll Cardiol 1995; 75:415A.

  Davies MG, Ramkumar V, Fulton GJ, Hagen P-O. Function of Adenosine A1 receptors in experimental vein grafts. FASEB J 1995; 9:A610.

  Svendsen E, Davies MG, Klyachkin ML et al. Short-term morphology of in situ vein grafts. Inter J Surg Pathol 1995; 2 (Supplement): 84.

  Annex BH, Davies MG, Channon K et al. Alteration of rabbit carotid artery vasomotor function by gene transfer with a replication deficient adenovirus. J Am Coll Cardiol 1995; 75:366A.

  Hopkin MA, Davies MG, Brockbank KGM, Hagen P-O. The influence of cooling (20°C) and rewarming (37°C) on vascular endothelial and smooth muscle cell function. FASEB J 1995; 9:A647.

  Fulton GJ, Davies MG, Barber L, Hagen P-O. Aminoguanidine prevents venous endothelial cell dysfunction induced by hyperglycemia. FASEB J 1995; 9:A321.

  Hagen P-O, Davies MG, Fulton GJ, Ramkumar V. Function of Adenosine A2 receptors in experimental vein grafts. FASEB J 1995; 9:A610.

  Fulton GJ, Davies MG, Hagen P-O. Oral L-arginine therapy improves the endothelial cell dysfunction induced by prolonged hypercholesterolemia. J Invest Surg 1995; 8:305.

  Fulton GJ, Davies MG, Hagen P-O. Kinetics of altered angiotensin II responses in experimental vein grafts. J Invest Surg 1995; 8:305.

  Anstadt MP, Perez-Tamayo RA, Davies MG et al. Aorto-coronary saphenous vein graft (SVG) function after mechanical cardiac massage. ASAIO (American Society for Artificial Internal Organs) J 1995; 41:19.

  Channon KM, Fulton GJ, Davies MG et al. An early increase in intimal Tissue Factor Protein expression precedes neointimal hyperplasia in venous bypass grafts. Circulation 1995; 92:I-359.

  Davies MG, Fulton GJ, Hagen P-O. A comparison of local and systemic angiotensin AT1 receptor antagonism on the development of experimental vein graft intimal hyperplasia. FASEB J 1996; 10:A620.

  Fulton GJ, Davies MG, Barber E et al. Locally applied antisense oligonucleotide to proto-oncogene c-myb inhibits the formation of intimal hyperplasia in experimental vein grafts. Ir J Med Sci 1996; 165:67.

  Fulton GJ, Channon KM, Davies MG et al. Differential alterations of Type III and IV collagen protein expression in experimental venous bypass grafts. J Am Coll Cardiol 1996; 76: 205A.

  Fulton GJ, Davies MG, Hagen P-O. Locally applied antisense oligonucleotide to PCNA inhibits intimal hyperplasia formation in experimental vein grafts. FASEB J 1996; 10:A619.

  Channon KM, Fulton GJ, Davies MG et al. Modulation of Tissue Factor protein in experimental vein bypass grafts Heart 1996; 75:P49.

  Channon KM, Fulton GJ, Davies MG et al. CD18 positive leukocytes mediate Tissue Factor expression in early experimental vein grafts. Circulation 1996; 94: I-695.

  Fulton GJ, Davies MG, Channon KM et al. Local delivery of an anti-Tissue Factor antibody decreases leukocyte infiltration but fails to limit intimal hyperplasia in experimental vein grafts. Circulation 1996; 94: I-4.

  Davies MG, Huynh TTT, Hagen P-O. Dopamine responses in veins, arteries and experimental vein bypass grafts. FASEB J 1997; 11: A261.

  Davies MG, Huynh TTT, Ramkumar V, Hagen P-O. G-protein expression in intimal hyperplasia. Microcirculation 1997; 4:140.

  Huynh TTT, Davies MG, Annex BA, Peters K, Hagen P-O. Alterations in Vascular Endothelial Cell Growth Factor expression in experimental vein bypass grafts. FASEB J 1997; 11: A338.

  Huynh TTT, Davies MG, Barber L, Dalen H, Svendsen E, Hagen P-O. Angiotensin II and vein graft intimal hyperplasia. Microcirculation 1997; 4:400.

  Fulton GJ, Channon KM, Davies MG et al. Alterations in vein graft matrix composition: analysis of collagen expression. Ir J Med Sci 1997; 167: 165.

  Fulton GJ, Channon KM, Davies MG et al. Efficient adenoviral gene transfer to vein grafts and native vessels. Ir J Med Sci 1997; 167: 344.

  Huynh TTT, Davies MG, Hagen P-O et al. Local treatment with Tissue Factor Pathway Inhibitor reduces the development of intimal hyperplasia in experimental vein grafts. Circulation 1997; 96: I-41.

  Daum G, Kalmes A, Levkau B et al. p38MAPK inhibits ras-dependent activation of mitogen activated protein kinase kinase-1 in oxidative stress signaling. FASEB J 1998; 11: A743.

  Fischer JW, Davies MG, Wight TN, Clowes AW. Versican is the predominant proteoglycan in flow accelerated neointimal hyperplasia of endothelialized baboon vascular grafts. Circulation 1998; 98: I-228.

  Huynh TTT, Abrahams G, Murray J, Brockbank KGM, Davies MG, Hagen P-O, Sullivan S. Remodeling of an acellular allogenic graft into a physiologic neovessel. Circulation 1999; 100 (suppl I): I-406.

  Davies MG, Fischer JW, Kenagy R, Lea H, Hawkins SA, Wight TN, Clowes AW. Time course of flow induced neointimal atrophy in endothelialized baboon vascular grafts. Circulation 1999; 100 (suppl I): I-708.

  Davies MG, Mason DP, Tran PK, Daum G, Clowes AW. Inhibition of intimal hyperplasia by the p38MAPK inhibitor SB203580. FASEB J 2000; 14: A450.

  Davies MG, Mason DP, Tran PK, Clowes AW. G-protein expression and intimal hyperplasia after arterial injury. FASEB J 2000; 14: A457 and Journal of Submicroscopic Cytology and Pathology 2000; 32:458.

  Davies MG, Kenagy RD, Fischer JW, Wight TN, Clowes AW. Flow-induced intimal atrophy in baboon PTFE grafts is associated with decreased smooth muscle cell proliferation, increased cell death, and degradation of the extracellular matrix protein versican. Journal of Submicroscopic Cytology And Pathology 2000; 32:442.

  Kovach S, Gorti R, Roztocil E, McKillop I, Green RM, Okada SS, Davies MG. Urokinase (uPA) activation of an unique G-protein associated Urokinase receptor (uPAR) induces smooth muscle cell proliferation. FASEB J 2001; 15: A1128.

  Tanski WJ, Roztocil E, Davies MG. Sphingose-1-phosphate induces Gαi coupled, PI3K dependent smooth muscle cell migration. J Surg Res 2001; 100:303 and FASEB J 2004; 18:A594 and Cardiovasc Pathol 2004; 13 (suppl 1): S54.

  Kenagy RD, Fischer JW, Davies MG, Berceli SA, Sandy J, Hawkins SM, Wight TN, Clowes AW ADAM-TS and Plasmin Mediated Degradation of Versican during Flow-Induced Intimal Atrophy in Baboon Polytetrafluorethylene (PTFE) Grafts. Arterioscler Thromb Vasc Biol 2002; 22; 878a.

  Tanski W, Roztocil E, Davies MG. Lysophosphatidic acid stimulates G-protein coupled, p38MAPK -dependent smooth muscle cell proliferation. J Am Coll Surg 2002; 195:S99.

  Fegley AJ, Tanski WJ, Roztocil E, Davies MG. Sphingose-1-phosphate stimulates smooth muscle cell migration through Gαi- and PI3-kinase-dependent p38MAPK activation. J Surg Res 2002; 107:281-282 and FASEB J 2004; 18:A594.

  Fegley AJ. Tanski WJ. Roztocil E. Zou Y, Davies MG. PKA signaling modulates smooth muscle cell proliferation after G-protein coupled stimulation. J Am Coll Surg 2003 197(suppl):S105 and Cardiovasc Pathol 2004; 13 (suppl 1): S47 and FASEB J 2004; 18:A593.

  Galaria II, Fegely AJ, Zou Y. Roztocil E, Tanski WJ, Davies MG. Differential regulation of ERK1/2 and p38MAPK by components of the rho signaling pathway during sphingosine-1-phosphate-induced smooth muscle cell migration. J Surg Res 2003; 114:247 and Cardiovasc Pathol 2004; 13 (suppl 1): S47 and FASEB J 2004; 18:A593.

  Nicholl SM, Roztocil E. Davies MG. Urokinase (uPA) induced smooth muscle cell responses require distinct ras and PI3K-dependent pathways. Cardiovasc Pathol 2004; 13 (suppl 1): S57 and FASEB J 2004; 18: A232.

  Roztocil E. Nicholl SM, Davies MG. Urokinase-induced smooth muscle cell proliferation requires plasmin-dependent epidermal growth factor receptor activation. Cardiovasc Pathol 2004; 13 (suppl 1): S154 and FASEB J 2004; 18:A593 and Arterioscler Thromb Vasc Biol 2004 24: e61. 

  Saad WEA, Ryan C, Fultz P, Davies MG, Gottlieb RH, Waldman DL. Safety and efficacy of fluoroscopic versus ultrasound guided core liver biopsies in live liver transplant donors. J Vasc Intervent Radiol 2004; 15:S202.

  Saad WEA, Davies MG, Lee DE, Sahler L, Patel N, Waldman DL. The natural history of hepatic artery stenosis in liver transplant recipients. J Vasc Intervent Radiol 2004; 15:S180.

  Saad WEA, Davies MG, Lee DE, Sahler L, Patel N, Waldman DL. Hepatic artery PTA after liver transplantation. J Vasc Intervent Radiol 2004; 15:S180.

  Saad WEA, Davies MG, Lee DE, Sahler L, Waldman DL. Transhepatic dilation on anastomotic biliary stricture in orthotopic liver transplants: significance of a patent hepatic artery J Vasc Intervent Radiol 2004; 15:S181.

  Saad WEA, You KS, Davies MG, Lee DE, Orloff MS, Waldman DL. Microbial contamination of bile following liver transplantation: de novo PTC versus indwelling biliary drains. J Vasc Intervent Radiol 2004; 15:S235.

  Tanski WJ, Roztocil E. Nicholl SM, Kim D, Davies MG. Sphingosine-1-phosphate-induced smooth muscle cell migration involves the Mammalian Target of Rapamycin. Arterioscler Thromb Vasc Biol 2004 24: e111.

  Nicholl SM, Zou Y Cheeran DD, Roztocil E, Davies MG. Expression and activation of Matrix Metalloproteinases and Tissue Inhibitors of MMPs in a murine vein graft model of intimal hyperplasia. Arterioscler Thromb Vasc Biol 2004 24: e60.

  Galaria II, Nicholl SM, Roztocil E, Davies MG. Sphingosine-1-phosphate induced smooth muscle cell migration requires src activation. J Am Coll Surg 2004; 199 (suppl): S104.

  Galaria II, Nicholl SM, Roztocil E, Davies MG. Plasmin induces smooth muscle cell proliferation through Gαi- and Gαq- mediated pathways. J Surg Res 2004; 121: 302.

  Roztocil E, Galaria II, Nicholl SM, Davies MG. Urokinase-induced smooth muscle cell migration requires both PI3K / akt and PI3K / ERK1/2 activation. J Surg Res 2004; 121: 290.

  Sivamurthy N, Davies MG. Endoluminal versus open mesenteric revascularization: short term benefits are not matched by longer term functional outcomes. Circulation 2004; 110 (supplement III):III-612.

  Saad N, Saad WEA, Davies MG, Waldman DL, Fultz PJ, Rubens D. Pseudo-aneurysms and the role of minimally invasive techniques in their management. 90th RSNA Proceedings 2005; pp 751.

  Saad N, Saad W, Lee DE, Waldman DL. Patel NC, Davies MG, Percutaneous and open renal revascularization have equivalent long-term functional outcomes. J Vasc Intervent Radiol 2005; 16 (supplement): S63.

  Saad N, Saad W, Lee DE, Waldman DL. Patel NC, Davies MG, Implications of early failure of Superficial Femoral Artery Endoluminal Interventions. J Vasc Intervent Radiol 2005; 16 (supplement):S27 and 91st RSNA Proceedings 2005; pp 53.

  Lee DE, Popuri D, Jain R, Patel NC, Saad W, Davies MG, Waldman DL. Internal iliac/Uterine Artery Embolization in the Setting of Acute Vaginal Bleeding. J Vasc Intervent Radiol 2005; 16 (supplement): S80.

  Roztocil E. Nicholl S, Davies MG. Kringle domain of urokinase induces receptor-independent smooth muscle cell migration. Vascular Medicine 2005; 10;123.

  Nicholl S, Roztocil E. Galaria II, Davies MG. Sphingosine-1-Phosphate induced smooth muscle cell migration requires rho-dependent akt activation Vascular Medicine 2005; 10; 174 and FASEB J 2007; 21:A1442.

  Saad N, Lee DE, Saad WEA, Patel NC, Waldman DL, Davies MG, Cryoplasty of infra-inguinal arterial stenoocclusive disease: Preliminary results. 91st RSNA Proceedings 2005; pp 513.

  Bressler E, Qi Y, Roztocil E, Nicholl SM, Davies MG. Urokinase-induced smooth muscle cell migration requires PKC-α and PKC-δ isoforms. J Surg Res 2006; 130: 267 and FASEB J 2007; 21:A751.

  Potack C, Roztocil E, Nicholl SM, Davies MG. Urokinase-induced smooth muscle cell migration involves the mammalian target of rapamycin.. J Surg Res 2006; 130: 234 and FASEB J 2007; 21:A750.

  Saad NEA, Saad WEA, Davies MG, Sahler LG, Patel NC, Lee DE, Kitanosono T, Sasson T, Waldman DL.Recannulation of tunneled internal jugular central venous catheters, which have been inadvertently discontinued. J Vasc Intervent Radiol 2006 17 (2 pt 2): S48.

  Saad WEA, Saad NEA, Davies MG, Bozorgzadeh A, Orloff M, Patel NC, Abt P, Sahler LG, Lee DE, Kitanosono T,Sasson T, Waldman DL. Trans-jugular Intra-hepatic Portosystemic Shunts (TIPS) for Immediate Pre-Transplant Portal Decompression in Adult Living Related Liver Transplant Recipient Candidates. J Vasc Intervent Radiol 2006; 17 (2 pt 2): S45.

  Saad WEA, Davies MG, Saad NEA, Patel NC, Sahler LG, Lee DE, Kitanosono T, Sasson T, Waldman DL. Dilation of Transplant Anastomotic Biliary Strictures Using a Combined Cutting-Conventional Balloon Protocol J Vasc Intervent Radiol 2006; 17 (2 pt 2): S30.

  Saad WEA, Davies MG, Patel NC, Sahler LG, Lee DE, Kitanosono T, Sasson T, Waldman DL. Development of a Dextro-Transhepatic Internal-External Biliary Drain for Liver Transplants with Biliary-Enteric Anastomoses. J Vasc Intervent Radiol 2006; 17 (2 pt 2): S42.

  Faranegan F, Harrod-Kim P, Patel N, Lee D, Saad W, Waldman D, Davies. MG. Endoluminal Mesenteric Revascularization: Long-Term Anatomic and Functional Outcomes. J Vasc Intervent Radiol 2006; 17: 200.

  Faranegan F, Harrod-Kim P, Lee D, Patel N, Sasson T, Waldman D, Davies. MG. Impact of chronic renal insufficiency on superficial femoral artery endoluminal interventions. J Vasc Intervent Radiol 2006; 17: 200.

  Bakken AM, Roztocil E, Nicholl SM, Davies MG. Enhanced sphingosine-1-phosphate mediated smooth muscle cell migration in metabolic syndrome is redox dependent. J Am Coll Surg 2006; 203 (suppl): S99 and FASEB J 2007; 21:A750.

  llig KA, Bakken AM, Davies MG. Cryo balloon angioplasty broadens the role of primary PTA and reduces the need for stenting in complex SFA lesions (TASC C and D). Vascular 2006; 14(suppl 1):S77-78.

  Saad WEA, Patel NC, Davies MG, Saad NEA, Sasson T, Lee DE, Kitanosono T, Sahler LG, Waldman DL. Percutaneous Transhepatic Balloon Dilation of Anastomotic Biliary Strictures in Liver Transplant Recipients: Description of the General Dilation Protocol and the Variations in Protocols and Controversies in the Literature. 92nd RSNA proceedings 2006; LL-VI2560, pp 966.

  Saad WEA, Davies MG, Sahler LG, Patel NC, Lee DE, Sasson T, Kitanosono T, Waldman DL. Endoluminal Angioplasty of Hepatic Arterial Stenosis in Liver Transplant Recipients: Technical Note and Complication Management. (RSNA Awarded Certificate of Merit) 92nd RSNA proceedings 2006; LL-VI3032, pp 971.

  Saad WEA, Davies MG, Patel NC, Sahler LG, Lee DE, Kitanosono T, Sasson T, Waldman DL. Transjugular Intrahepatic Porto-systemic Shunts (TIPS) Creation: A Comparative Literature Review and Analysis for the Past Three Years (2004-2006) between Stent-grafts and Bare-stents. 92nd RSNA proceedings 2006; LL-VI3027, pp 970.

  Saad WEA, Davies MG, Patel NC, Sahler LG, Lee DE, Kitanosono T, Sasson T, Waldman DL. Implication of Transjugular Intrahepatic Portosystemic Shunts (TIPS) Placement on the Intra-Operative Technical Aspects of Subsequent Liver Transplantation Procedures: The Ideal Stent Placement for the Reduction of Intraoperative Difficulties. 92nd RSNA proceedings 2006; LL-VI3028, pp 970.

  Saad WEA, Davies MG, Patel NC, Sahler LG, Lee DE, Kitanosono T, Sasson T, Waldman DL. Percutaneous Transhepatic Techniques for Removal of Endoscopically (ERCP) Placed Biliary Stents. (RSNA Awarded Certificate of Merit) 92nd RSNA proceedings 2006; LL-VI3026, pp 970.

  Bakken AM, Roztocil E, Qi Y, Galaria II, Nicholl SM, Davies MG. S1P induced VSMC migration via activation of NAD(P)H oxidase requires Gα12/13 protein mediated phospholipase C activation. J Surg Res 2007; 137:175 and FASEB J 2007; 21:A69.

  Protack CD, Bakken AM, Roztocil E, Qi Y, Nicholl SM, Davies MG. Mechanisms of urokinase mediated activation of the mammalian target of rapamycin (mTOR). J Surg Res 2007; 137:345 and FASEB J 2007; 21:A192.

  Bakken AM, Roztocil E, Nicholl SM, Davies MG. Sphingosine-1-phosphate induced smooth muscle cell migration requires receptor tryosine kinase receptor transactivation. J Surg Res 2007; 137:347 and FASEB J 2007; 21:A518.

  Bakken AM, Roztocil E, Nicholl SM, Davies MG. Kringle fragment of urokinase activates focal adhesion kinase through an EGFR-PI3K mechanism. J Surg Res 2007; 137:345 and FASEB J 2007; A1441.

  Zou Y, Qi Y, Roztocil E, Nicholl SM, Davies MG. Patterns Of Kinase Activation Induced By Injury In The Murine Femoral Artery. J Surg Res 2007; 137:175 and FASEB J 2007; 21:A1128.

  Saad N, Saad WA, Davies MG, Waldman DL. Percutaneous Transluminal Angioplasty (PTA) of infra-genicular arteries for limb salvage. J Vasc Intervent Radiol 2007; 18: S42.

  Saad N, Saad WA, Davies MG, Waldman DL. Percutaneous Transluminal Angioplasty of bypass graft (BPG) stenoses should be first line therapy. J Vasc Intervent Radiol 2007; 18: S106.

  Saad N, Saad WA, Davies MG, Waldman DL. Percutaneous Transluminal Angioplasty (PTA) of recurrent stenosis after primary infra-inguinal PTA. J Vasc Intervent Radiol 2007; 18: S41.

  Saad N, Saad WA, Davies MG, Patel NC, Sasson T, Waldman DL. Gestational and Puerperial Percutaneous Nephrostomy Drain Placement: Clinical Outcomes. J Vasc Intervent Radiol 2007; 18: S31.

  Saad WEA, Westesson KE, Virdee S, Davies MG, Hoadley K, Patel NC, Sahler LG, Lee DE, Kitanosono T, Sasson T, Waldman DL. Inadvertent Discontinuation of Percutaneous Trans-Hepatic Biliary Drains: Incidence and Percutaneous Management. J Vasc Intervent Radiol 2007; 18: S5.

  Saad WEA, Davies MG, Saad NEA, Westesson KE, Patel NC, Sahler LG, Lee DE, Kitanosono T, Sasson T,Waldman DL. Percutaneous Trans-Hepatic Balloon Dilation of Biliary Enteric Anastomoses: Native versus Transplanted Livers. J Vasc Intervent Radiol 2007; 18: S6.

  Saad WEA, Davies MG, Ryan CK, Rubens DJ, Westesson KE, Patel NC, Sahler LG, Lee DE, KitanosonoT, Sasson T, Waldman DL. Incidence of Arterial Injuries Following Right-Lobe Ultrasound-Guided Random Core Liver Biopsies in Human Subjects J Vasc Intervent Radiol 2007; 18: S127.

  Davies MG, Roztocil E, Nicholl S. Selective receptor tryosine kinase receptor transactivation is required for receptor mediated urokinase induced smooth muscle cell migration FASEB J 2007; 21:A751.

  Saad WEA, Davies MG, Sahler LG, Patel NC, Lee DE, Waldman DL. Non-obstructive Arterial Complications of Liver Transplantation: Management and Imaging Characteristics Pre- and Post-Minimal Invasive Interventions. 93rd RSNA proceedings 2007; LL-VI3032, pp. 

  Saad WEA, Davies MG, Waldman DL. Venous Complications of Liver Transplantation: Management and Imaging Characteristics Pre- and Post-Minimal Invasive Interventions. 93rd RSNA proceedings 2007; LL-VI3032, pp.

  Saad WEA, Davies MG, Sahler LG, Patel NC, Lee DE, Waldman DL. Pulmonary Artery Embolization: Indications and Techniques. 93rd RSNA proceedings 2007; LL-VI3032, pp.

  Saad WEA, Davies MG, Westesson KE, Saad NE, Waldman DL. Hepatic Artery Stenosis after Liver Transplantation: Impact of Angioplasty and/or Stent Placement on Arterial Patency and Graft Survival. 93rd RSNA proceedings 2007; LL-VI3032, pp.

  Nicholl S, Roztocil E, Davies MG. Role of sphingosine-1-phosphate (S1P) in insulin signaling. Circulation 2007; 116 (suppl):II_239.

  Bakken AM, Protack CD, Saad WEA, Lee DE, Waldman DL, Davies MG. Longterm Outcomes of Primary Angioplasty and Primary Stenting of Central Venous Stenoses in Hemodialysis Patients (J Vasc Surg 2007 Apr; 45 (4): 776-783) Featured abstract: J Vasc Interv Radiol 2007; 18(7):947.

  Protack CD, Bakken AM, Saad WEA, Illig KA, Waldman DL, Davies MG. Radiation arteritis: a contraindication to carotid stenting? (J Vasc Surg 2007; 45(1):110-7) Featured abstract: Eur J Vasc Endovasc 2007; 33: 129-130.

  Protack CD, Bakken AM, Patel NC, Saad WEA, Waldman DL, Davies MG. Long-Term Outcomes of Catheter Directed Thrombolysis for Ilio-Femoral Deep Venous Thrombosis (DVT): Is There a Need for an Inferior Vena Cava (IVC) Filter? (J Vasc Surg 2007 May; 45 (5): 992-997) Featured abstract: J Vasc Interv Radiol 2007; 18(8):1066.

  Roztocil E, Nicholl SM, Davies MG. Mechanisms of Sphingosine-1-Phosphate induced akt dependent smooth muscle cell migration. J Surg Res 2008; 144:327-8.

  Roztocil E, Nicholl SM, Davies MG. Insulin induced Epidermal Growth Factor Receptor trans activation in smooth muscle cells is ADAM-dependent. J Surg Res 2008; 144:262-3.

  Zou Y, Qi Y, Roztocil E, Nicholl SM, Lumsden AB, Davies MG. Patterns of Urokinase and Gelatinase activation induced by injury in the murine femoral artery J Surg Res 2008; 144:414.

  Protack C, Bakken AM, Saad WE, Davies MG. Impact of elevated fasting blood glucose on carotid artery stenting outcomes. J Vasc Interv Radiol 2008; 19:S31.

  Protack C, Bakken AM, Saad WE, Davies MG. Renal artery interventions during EVAR: a greater potential of subsequent failure? J Vasc Interv Radiol 2008; 19:S53.

  Protack CD, Bakken AM, Roztocil E, Nicholl SM, Davies MG. Sphingosine-1-phosphate mediated increases in urokinase expression and activity facilitates vascular smooth muscle cell migration. J Am Coll Surg 2008; 207:S47.

  Roztocil E, Nicholl SM, Davies MG. Selective receptor tryosine kinase receptor transactivation is required for receptor mediated urokinase induced smooth muscle cell migration. J Surg Res 2009; 151:302.

  Roztocil E, Nicholl SM, Davies MG. G〈i2 and Gαi3 G-protein coupled MAPK activation in smooth muscle cell proliferation. J Surg Res 2009; 151:302.

  Zou Y, Qi Y, Davies MG. Patterns of G-protein expression induced by injury in the murine femoral artery. J Surg Res 2009; 151:302.

  Roztocil E, Nicholl SM, Davies MG. S-1-P activates focal adhesion kinase through G-protein mediated src activation and requires EGFR transactivation. J Surg Res 2009; 151:302.

  Younnes HK, Davies MG, Bismuth J, Canter D, Charlteon-Ouw KM, Harris PW, Zaporteza KE, Lumsden AB, Peden EK Are thoracic endovascular aortic repair (TEVAR) outcomes gender dependent? J Surg Res 2009; 151:285.

  Saad WEA, Wilson IJ, Davies MG, Westesson KE, Darwish WM, Waldman DL. IV Morphine Augmentation for Post-Operative T-Tube Cholangiography in Orthotopic Liver Transplant Recipients with Choledocho-Choledochostomies J Vasc Interv Radiol 2009; 20 (1 pt 2): S14.

  Younes HK, Z Garami, Bismuth J, Davies MG, Lumsden AB. Real Time Intracranial Monitoring During Stent Placement in the Middle Cerebral Artery using TCD. Vasc Med 2009 14: 169-183.

  Younes HK, Bismuth J, Davies MG, Lumsden AB. New Dimensions in Diagnostic Imaging of the Aorta. Vasc Med 2009 14: 169-183.

  Younes HK, Bismuth J, Davies MG, Lumsden AB. Outcomes of SFA Recannulization After Failed Femoro-Popliteal Bypass - Shifting The Redo Paradigm. Vasc Med 2009 14: 169-183.

  Younes HK, Bismuth J, Davies MG, Lumsden AB. The Dichotomy of Renal Insuffiency Influence on the Outcome of Thoracic Endovascular Aortic Repair: Creatinine vs. GFR. Vasc Med 2009 14: 169-183.

  Davies MG. Proximal AV fistula should always be done first, in preference to more distal access! Vascular 2009; 17(Suppl 2):S84.

  Davies MG. Is Renal Angioplasty Still Justified. Vascular 2009; 17(Suppl 2):S79.

  Davies MG, Bismuth J, Naoum JJ, Mohiuddin IT, Peden EK, Lumsden AB Renal parenchymal preservation after percutaneous renal angioplasty and stenting. J Vasc Surg 2009; 49: (Suppl 1) S3-S4.

  Davies MG, Bismuth J, Naoum JJ, Mohiuddin IT, Peden EK, Lumsden AB. Outcomes of Interventions for Recurrent Disease after Endoluminal Intervention for Superficial Femoral Artery Disease. J Vasc Surg 2009; 49: (Suppl 1) S1.

  Younnes HK, Harris P, Bismuth J, Davies MG, Lumsden AB. Acute Aortic Treatment - Time to Change the Paradigm. J Vasc Surg 2009; 49: (Suppl 1) S49.

  Garami Z, Bismuth J, Davies MG, Lumsden AB. Transcranial Doppler Monitoring is Vital For Thoracic Endograft Placement. J Vasc Surg 2009; 49: (Suppl 1) S18-S19.

  Davies MG, Bismuth J, Saad WE, Naoum JJ, Peden EK, Lumsden AB Outcomes of endoluminal re-intervention for recurrent disease after percutaneous iliac angioplasty and stenting. J Vasc Surg 2009; 50: 967.

  Darwish WM, Saad WE, Davies MG, Bulant D, Waldman DL. Transjugular Intrahepatic Portosystemic Shunts in Liver Transplant Recipients for Management of Refractory Ascites: Clinical Outcome. J Vasc Interv Radiol 2010; 20 (S2). S34.

  Saad WE, Darwish WM, Davies MG, Waldman DL. Transhepatic Balloon Dilation of Anastomotic Biliary Strictures in Liver Transplant Recipients: A Comparison between a Conventional Balloon Protocol and a Combined Cutting- Conventional Balloon Protocol. J Vasc Interv Radiol 2010; 20 (S2): S26.

  Davies MG. The clotted graft and fistula - the right way to do it. Vascular 2010; 18(Suppl 1): S3.

  Anaya-Ayala JE, Cheema ZF, Naoum JJ, Bismuth J, Davies MG, Lumsden AB, Peden EK. Is distal Revascularization and Interval Ligation (DRIL) procedure an effective treatment for Hemodialysis access-induced “Steal” Syndrome? J Vasc Access 2010; 11(Suppl2): S12.

  Anaya-Ayala JE, Cheema ZF, Naoum JJ, Bismuth J, Davies MG, Lumsden AB, Peden EK. Outcomes with Lower Extremity Arteriovenous Access for Hemodialysis. J Vasc Access 2010; 11(Suppl2): S13.

  Collado E, Garcia C, Hodge M, Gortes V, Davies MG, Lumsden AB, Garami Z. Pitfalls of transcranial Doppler Evaluation: How to beath the learning curve. Cerebrovasc Dis 2010; 29(suppl I):I-29.

  Garami Z, Bismuth J, Davies MG, Lumsden AB. How fast is vertebral steal reversed? Real time TCD monitorig during stent placement in the left subclavian artery. Cerebrovasc Dis 2010; 29(suppl I):I-38.

  Garami Z, Diaz O, Davies MG, Volpi J. Fusion Imaging after stent placement in the middle cerebral artery. Cerebrovasc Dis 2010; 29(suppl I):I-18.

  Davies MG. Percutaneous renal artery stenting is safe even in patients with single functioning Kidneys. Vascular 2010; 18(Suppl 2): S71.

  Anaya-Ayala JE, Obilom C, Cheema ZF, Naoum JJ, Bismuth J, Davies MG, Lumsden AB, Peden EK. Clinical outcomes with covered stent placement for central venous occlusive disease in hemodialysis patients. J Vasc Surg 2010; 52:804.

  Davies MG, Bismuth J, Naoum JJ, Peden EK, Lumsden AB. Impact of elevated fasting blood glucose on the outcome of carotid artery stenting. J Vasc Surg 2010; 52:808 158. Anaya-Ayala JE, Bismuth J, Davies MG, Lumsden AB Successful Robot-assisted Pulmonary Artery Stenting of high grade anastomotic artery stenosis following Single Lung Transplantation. J Vasc Surg 2010; 52:813.

  Smolock CJ, Davies MG, Anaya Ayala J, Bismuth J, ElSayad HE, Naoum JJ, Peden EK, Lumsden AB. Impact of Metabolic syndrome on SFA interventions. J Vasc Surg 2010; 52 (6):1734.

  Smolock CJ, Anaya Ayala J, Bismuth J, Karmonik C, Davies MG, Lumsden AB. Dyna CT Scanning, image fusion, and virtual guidance systems for direct sac access in therapy of persistent Type II Endoleaks after EVAR. J Vasc Surg 2010; 52 (6):1737.

  Duru EA, Fu Y, Davies MG. Modulation of inflammatory Markers by S-1-P in vitro Metabolic Syndrome. J Surg Res 2011; 165(2):342.

  Duru EA, Fu Y, Davies MG. Modulation of Leptin, Adiponectin, and Resistin Expression in in vitro Metabolic Syndrome. J Surg Res 2011; 165(2): 342.

  Duru EA, Fu Y, Davies MG. Differential Modulation of Proteases and Protease Inhibitors Expression in in vitro Metabolic Syndrome. J Surg Res 2011; 165(2):342.

  Davies MG, Duru EA, Fu Y Role of S-1-P Receptors and Human Vascular Smooth Muscle Cell Migration in Metabolic Syndrome. J Surg Res 2011; 165(2): 343.

  Davies MG, Duru EA, Fu Y S-1-P mediated cell migration and invasion are Gβγ and β−arrestin dependent and change under metabolic stress. J Surg Res 2011; 165(2): 343.

  Davies MG, Duru EA, Fu Y. Urokinase requires NAD(P)H oxidase to transactivate EGFR. J Surg Res 2011; 165(2): 342.

  Davies MG, Duru EA, Fu Y. Transactivation of EGFR1 by urokinase requires the co-receptor EGFR4. J Surg Res 2011; 165(2): 342.

  Fu Y, Duru EA, Davies MG. Effect of metabolic syndrome on the response to arterial injury. J Surg Res 2011; 165(2):342.

  Fu Y, Duru EA, Davies MG. Changes in MMP2 system following arterial injury in metabolic syndrome. J Surg Res 2011; 165(2): 342.

  Fu Y, Duru EA, Davies MG. Changes in uPA following arterial injury in metabolic syndrome. J Surg Res 2011; 165(2): 342.

  Davies MG, Balancing the scorecard - defining and reporting academic activity: the academie RVU. J Surg Res 2011; 165(2): 174.

  Davies MG, Bismuth J, Lumsden AB. Regionalization of Vascular Surgery Education - The Fellows’ Bootcamp. J Surg Res 2011; 165(2):333.

  Naoum JJ, Bismuth J, Davies MG Open arterial revascularization of the critically ischemic foot using arterial homograft. J Surg Res 2011; 165(2): 184.

  Smolock CJ, Anaya Ayala J, Bismuth J, ElSayad HE, Naoum JJ, Peden EK, Lumsden AB, Davies MG, Clinical Efficacy of Concomitant Tibial Interventions Associated with SFA Interventions in Critical Limb Ischemia. J Vasc Surg 2011; 53:556-7.

  Anaya-Ayala JE, Smolock CJ, An R, Naoum JJ, Bismuth J, Peden EK, Lumsden AB, Davies MG. Clinical efficacy of Endoluminal Interventions for Below Knee Occlusive Disease. J Vasc Surg 2011; 53:556.

  Saad WEA, Darwish WM, Anderson CL, Sabri SS, Davies MG, Angle JF, Turba UC, Caldwell SH, Al-Osaimi AM, Park A-W, Matsumoto AH. The Effect of Balloon-Occluded Retrograde Transvenous Obliteration (BRTO) on the Model for End Stage Liver Disease (MELD) Score. J Vasc Interv Radiol 2011; 22(3S): S34-35.

  Saad WEA, Anderson CL, Darwish WM, Davies MG, Waldman DL, Angle JF, Turba UC, Sabri SS, Stone J, Kitanosono T, Park A-W, Matsumoto AH. Comparison between the Technical Results of TIPS in Liver Transplant Recipients and Native (Non-transplanted) Liver Patients. J Vasc Interv Radiol 011; 22(3S): S35.

  Saad WEA, Hubbard J, Lippert A, Davies MG, Dasgupta N, Angle JF, Turba UC, Sabri SS, Schmitt T, Kumer S, Park A-W, Matsumoto AH. Doppler Diagnosis of Splenic Steal Syndrome in Liver Transplant Recipients with Test Balloon-Occlusion of the Splenic Artery. J Vasc Interv Radiol 2011; 22(3S): 137-8.

  Saad WEA, Anderson CL, Darwish WM, Davies MG, Waldman DL, Angle JF, Turba UC, Sabri SS, Stone J, Kitanosono T, Park A-W, Matsumoto AH. Extrahepatic Pseudoaneurysms of the Hepatic Artery in Liver Transplant Recipients: A Changing Etiology and Management Over the Past Decade? J Vasc Interv Radiol 2011; 22(3S): S138.

  Cheema, ZF, Anaya-Ayala JE, Birmbaum I, Seethamraju H, M. Loebe; B. Ramlawi, Davies MG, Reardon MJ, Lumsden AB The Role of Pulmonary Artery Stents In The Management of Pulmonary Artery Stenosis After Lung Transplant. J Vasc Interv Radiol 2011; 22(3S): S19.

  Lumsden AB, Davies MG. Total Endovascular Series - Aorta II. Methodist DeBakey Cardiovascular Journal 2011; 7(Suppl 1): S1.

  Davies MG, Lumsden AB. Development of the Acute Aortic Treatment Center at Methodist. Methodist DeBakey Cardiovascular Journal 2011; 7(Suppl 1): S2.

  Karmonik C, Duran C, Shah D, Anaya-Ayala JE, Davies MG, Lumsden AB, Bismuth J. Quantification of Changes in Septal Motion During Follow-Up in Aortic Dissections. J Vasc Surg 2011; 53 (suppl S):22S.

  Cassidy D, Karmonik C, Shah S, Anaya-Ayala J Davies MG, Lumsden AB, Bismuth J, Aortic Wall compliance Recovery during intra-mural hematoma healing. J Vasc Surg 2011; 53 (suppl S):25S.

  Naoum JJ, Street T, Chaline N, Bismuth J, ElSayad H, Hassoun H, Peden EK, Davies MG, Lumsden AB. A simplified Stratification sytem is effective at selecting patients with a high likelihood of hypercoaguable disorders. J Vasc Surg 2011; 53 (suppl S):72S.

  Smolock CJ, Anaya-Ayala JE, Bismuth J, Naoum JJ, ElSayad HE, Hassoun H, Peden EK, Lumsden AB, Davies MG. Outcomes of Femoro-popliteal Interventions in the Hemodialysis Dependent Patient. J Am Coll Surg 2011; 213 (suppl 3):S161.

  Anaya-Ayala JE, Colvard BD, Cmolock CJ, Cheema ZF, Ramlawi, B, Lumsden AB, Reardon MJ, Davies MG. Endovascular Exclusion To Avoid Aortic Cross Clamping And Facilitate Removal Of An Errant Intravascular Pedicle Spinal Fixation Screw. J Vasc Surg 2011; 54:927.

  Smolock CJ, Anaya-Ayala JE, Bavare C, Patel MS, Bismuth J, Naoum JJ, ElSayad HE, Hassoun H, Peden EK, Lumsden AB, Davies MG. Current Efficacy of Open and Endovascular Interventions for Advanced Superficial Femoral Artery Occlusive Disease. J Vasc Surg 2011; 54:1866.

  Bavare C, Street T, Peden EK, Davies MG, Naoum JJ. Early Experience in the use of Stent Grafts to Convert Unusable Arteriovenous Fistulas into a Functioning Hemodialysis Access. J Vasc Surg 2011; 54:1864.

  Patel M, Bavare C, Smolock CJ, Anaya-Ayala JE, Lumsden AB, Davies MG. Pharmacomechanical catheter directed thrombolysis to tret IVC Filter thrombosis. J Vasc Intervent Radiol 2012; 23: S119.

  Anaya-Ayala JE, Adams C, Bavare C, Ismail J, Bismuth J, Peden EK, Lumsden AB, Davies MG, Naoum JJ. Early outcomes of the “hybrid”graft used as a conduit for hemodialysis access. J Vasc Intervent Radiol 2012; 23: S171.

  Karmonik C, Bismuth J, Anaya-Ayala JE, Naoum JJ, ElSayad HE, Hassoun H, Peden EK, Lumsden AB, Davies MG. Non-Laminar Flow and Low Wall Shear Stress In Arteriovenous Access Grafts Correlate with Pressure Differences: A Computational Fluid Dynamics Study. J Vasc Intervent Radiol 2012;23: S40.

  Simon PO, Saad WE, Nicholson D, Bernhard MR, Turba UC, Davies MG, Sabri SS, Stone J, Park A. Angle JF, Matsumoto AH. Balloon-expandable stent-grafts for instent restenosis in atherosclerotic renal artery stenosis with prior clinical response. J Vasc Intervent Radiol 2012;23: S59.

  Davies MG. Carotid Ultrasound – Protocol. Methodist DeBakey Cardiovascular Journal 2012; 8(Suppl 1): S11.

  Davies MG. Carotid Ultrasound after stent placement. Methodist DeBakey Cardiovascular Journal 2012; 8(Suppl 1): S11-12.

  Anaya-Ayala JE, ElSayad HE, Hassoun H, Peden EK, Lumsden AB, Davies MG. Patient Centered Outcomes Following Endovascular Intervention For Critical Limb Ischemia. J Vasc Surg 2012; 55(Supplement):18S

  Anaya-Ayala JE, ElSayad HE, Hassoun H, Peden EK, Lumsden AB, Davies MG. Ulcer Healing and Prevention of Limb Loss following Endovascular Tibial Artery Interventions in patients presenting with tissue loss. J Vasc Surg 2012: 55(Supplement):7S.

  Anaya-Ayala JE, Smolock CJ, Adams MK, Patel MS, Duran CA, Bavare C, ElSayad HE, Lumsden AB, Davies MG. Outcomes In The Elderly Of Open And Endovascular Interventions For Advanced Superficial Femoral Artery Occlusive Disease. J Vasc Surg 2012; 56:880.

  Anaya-Ayala JE, Smolock CJ, Adams MK, Patel MS, Duran CA, Bavare C, ElSayad HE, Lumsden AB, Davies MG. Ulcer Healing and Prevention of Limb Loss following Endovascular Tibial Artery Interventions in patients presenting with tissue loss. J Vasc Surg 2012; 56:881.

  Anaya-Ayala JE, Zamani N, Ismail N, Lu T, Duran CA, ElSayad HE, Lumsden AB, Davies MG, Peden EK. Surgical Reconstruction of the cephalic Arch for the management of Dysfunctional Brachiocephalic Arteriovenous Fistulae. J Vasc Surg 2013; 57:289.

  Ferdinand AJ, Simon PO, Saad WE, Davies MG, Turba UC, Sabri SS, Blechman AB, Upchurch GR, Angle JF, Matsumoto AH. Primary balloon expandable covered stents vs. primary bare stents for mesenteric ischemia: patency and clinical outcomes. J Vasc Intervent Radiol 2013; 24 (Supplement): S6.

  Saad WE, Nicholson D, Wagner C, Short RF, Davies MG, Turba U, Sabri, SS, Al-Osaimi AM, Angle JF, Caldwell SH, Matsumoto AH. Balloon-Occluded Transvenous Obliteration (BRTO) of gastric varices without an indwelling balloon: comparison between conventional BRTO with an indwelling balloon vs. intraprocedural replacement of the balloon with an Amplatzer vascular plug. J Vasc Intervent Radiol 2013; 24(Supplement): S61.

  Saad WE, Fischman AM, Frey G, Brown DB, Schenning R, Kim S, Kalva SP, Dariushnia S, Wagner C, Naidu SG, Saad NE, Sabri, SS, Dawish WM, Angle JF, Al-Osaimi AM, Davies MG, Paz-Fumagalli R, Darcy M, Caldwell SH, Kaufman J, Matsumoto AH. Balloon-Occluded Transvenous Obliteration (BRTO) utilizing 3% sodium tetradecyl sulfate(STS) foam for the management of gastric variceal bleeding: a multicenter USA study of 100 patients. J Vasc Intervent Radiol 2013; 24(Supplement): S62.

  Saad WE, Brown DB,, Schenning R, Wagner C, Kim S, Frey G, Fischman AM, Kalva SP, Dariushnia S, Naidu SG, Dawish WM, Saad NE, Sabri, SS, Al-Osaimi AM, Davies MG, Darcy M, Paz-Fumagalli R, Caldwell SH, Matsumoto AH, Kaufman J. Clincial Outcomes of Balloon-Occluded Transvenous Obliteration (BRTO) only Versus BRTO and TIPS for the management of gastric variceal bleeding: a multicenter USA study. J Vasc Intervent Radiol 2013; 24(Supplement): S63.

  Saad WE, Khaja MS, Schwaner SL, Davies MG, Nicholson D, Pelletier SJ, Al-Osaimi AM, Angle JF, Matsumato AH. Portal vein stenosis in adult whole graft liver transplant recipients: primary management with transhepatic angioplasty. J Vasc Inter Radiol 2014;25 (supplement): S153.

  Younes HK, Davies MG. Defining and reporting academic activity: the Academie RVU can justify the mission J Vasc Surg 2014; 59(Suppl):64S.

  Loh TM, Bennett ME, Davies MG, Peden EK. Revision Using Distal Inflow: A Safe and Effective Treatment for Ischemic Steal Syndrome After Access Creation. J Vasc Surg 2014; 60:1726.

  Zivi I, Diaz O, Klutznik R, Collado E, Guel M, Davies MG, Lumsden AB, Garami Z. Waveform shapes predicting vasospasm in subarachnoid hemorrhage. Cerebrovasc Dis 2014; 37:34.

  Davies MG, El Sayed HF. Equivalent Outcomes with Standard and Heparin-Bonded Expanded Polytetrafluoroethylene Grafts used as Conduits for Hemodialysis Access. J Vasc Surg 2015; 62(3): ):807.

  Davies MG, El Sayed HF. Outcomes of Native Superficial Femoral Artery Chronic Total Occlusion Recanalization after Failed Femoro-Popliteal Bypass - Should We Shift the Redo Paradigm? J Vasc Surg 2015; 62(3):795.

  Alarhayem AQ, Davies MG. Malignant Vascular tumors; A Nationwide Analysis. J Vasc Surg 2016; 63(Supplement S): S1955.

  Davies MG, Haider GM, El Sayed HF. Outcomes of Intervention for Cephalic Arch Stenosis in Brachiocephalic Arterio-Venous Fistulas J Vasc Surg 2016; 64 (3): 839-840.

  Davies MG, Haider GM, Hicks TD, El Sayed HF. WIFI Scores Predict Outcomes After Tibial Intervention In Patients With Diabetes And ESRD J Vasc Surg 2016; 64 (3): 837.

  Baer HE, Laux A, Swain S, Pounds L, Hicks T, Sideman M, Haidar G, Davies MG. Malignant Iliac Vein Compression with Symptomatic Iliofemoral Deep Venous Thrombosis. J Vasc Surg: Venous and Lymphatic Disorders 2017; 5(1):166.

  Baer HE, Swain S, Hicks T, Sideman M, Pounds L, Khausik D, Rodriguez R, Davies MG, Haidar G, Laux A. Efficacy of Primary Inferior Vena Cava Closure in the Setting of Advanced Renal Cell Carcinoma Venous Tumor Thrombus. J Vasc Surg: Venous and Lymphatic Disorders 2017; 5(1):171.

  Baer-Bositis HE, Hicks TD, Haider GM, Sideman MJ, Sheehan MK, Pounds LL, Davies MG. Outcomes Of Re-Intervention After Tibial Endovascular Intervention. J Vasc Surg 2017; 65:e3.

  Hui S, Folsom R, Killewich L, Vu M, Li C, Michalek J, Trevino A, Davies MG, Lori Pounds LL.Comparison of Preoperative and Intraoperative Vein Mapping Sizes for Arteriovenous Fistula Creation. J Vasc Surg 2017; 65:e11-e12.

  Baer-Bositis HE, Hicks TD, Haider GM, Sideman MJ, Pounds LL, Davies MG. Outcomes of tibial endovascular intervention for rest pain in patients with ESRD on dialysis. Ann Vasc Surg 2017; 41:10.

  Baer-Bositis HE, Hicks TD, Haider GM, Sideman MJ, Sheehan MK, Pounds LL, Davies MG. Outcomes of tibial endovascular Interventions in patients with poor pedal runoff. J Vasc Surg 2017; 65(3):e3.

  Davies MG, Hicks TD, Haider GM, Sideman MJ, Sheehan MK, Pounds LL. Upper Extremity Interventions For Critical Ischemia. J Vasc Surg 2017; 65(6):26S-7S.

  Baer HE, Hicks TD, Haidar GM, Sheehan MK, Sideman MJ, Pounds LL, Davies MG. Getting to Choosing Wisely: The Value of a PE Clinical Decision Tool to Enhance Appropriateness of Care. J Vasc Surg. 2017; 66(3):e58-9.

  Cheun T, Haider GM, Hicks TD, Pounds LL, Sideman MJ, Davies MG Implications of Early Failure of Isolated Tibial interventions. J Vasc Surg 2017; 66(4):e93.

  Cheun T, Hicks TD, Haider GM, Pounds LL, Sideman MJ, Davies MG. Upper Extremity Endovascular Interventions for Symptomatic Vascular Access-induced Steal Syndrome. J Vasc Surg 2017; 66(4):e95.

  Huang BY, Baer HE, Davies MG. Vascular Surgery Training Websites: An Evaluation of the Availability, Accessibility, and Quality of Online Content for Residency and Fellowship Applicants: Much Work Needs to be Done! J Am Coll Surg 2017; 225(4) Suppl 2: e162–e163.

  Cheun T, Jayakumar L, Sheehan MK, Sideman MJ, Pounds LL, Davies MG. Outcomes of Isolated Inframalleolar (Pedal Artery) Interventions for Limb-Threatening Critical Ischemia. J Vasc Surg 2018: 67 (Suppl): e49-e50.

  Cheun T, Davies MG. Impact of Goal directed Statin Therapy on Open and Endovascular Interventions for Claudication due to SFA disease. J Vasc Surg 2018 (in press).

  Cheun T, Davies MG. Influence of Heel Ulceration on Limb Salvage after Open and Endovascular Intervention for Limb Threatening Critical Ischemia. J Vasc Surg 2018 in press).

   

• Clinical

  Board Certifications

  • 2001 - Vascular Surgery-American Board of Surgery
  • 1998 - General Surgery-American Board of Surgery